FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Herbert Meltzer

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Rats

Activities & Behaviors

Schizophrenic Psychology

Concepts & Ideas

Anatomy

Blood Platelets

Co-author Network

Publications

TOP 3
Arun K Tiwari; Caroline Weber; Clement Zai; Eva J Brandl; Margaret K Hahn; James L Kennedy; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; Daniel J Müller
Association of a functional polymorphism in neuropeptide y with antipsychotic-induced weight gain in schizophrenia patients.
Masakuni Horiguchi; Mei Huang; Karu Jayathilake; Adesewa E Adelekun; Kayleen E Hannaway; Herbert Y Meltzer
D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats.
Herbert Y Meltzer
Update on typical and atypical antipsychotic drugs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Herbert Meltzer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Arun K Tiwari; Caroline Weber; Clement Zai; Eva J Brandl; Margaret K Hahn; James L Kennedy; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; Daniel J Müller
Association of a functional polymorphism in neuropeptide y with antipsychotic-induced weight gain in schizophrenia patients.
Journal of clinical psychopharmacology 2013;33(1):11-7.
2013: Masakuni Horiguchi; Mei Huang; Karu Jayathilake; Adesewa E Adelekun; Kayleen E Hannaway; Herbert Y Meltzer
D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats.
Behavioural brain research 2013;238():36-43.
2013: Herbert Y Meltzer
Update on typical and atypical antipsychotic drugs.
Annual review of medicine 2013;64():393-406.
2012: Herbert Y Meltzer; Perry Peters; Daniel P van Kammen; Kimberly Vanover; David M Weiner; Helio Elkis; Uli Hacksell
Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: comparison with reference dose risperidone, 6mg/day.
Schizophrenia research 2012;141(2-3):144-52.
2012: Herbert Y Meltzer
Clozapine: balancing safety with superior antipsychotic efficacy.
Clinical schizophrenia & related psychoses 2012;6(3):134-44.
2012: Gwyneth Zai; Nabilah I Chowdhury; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller; Steven G Potkin; Renan Souza; Arun K Tiwari; Clement Zai; James L Kennedy
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
Progress in neuro-psychopharmacology & biological psychiatry 2012;39(1):96-101.
2012: Anna C Need; Anu Putkonen; Eila Repo-Tiihonen; Peter Rosenquist; Kevin V Shianna; Jari Tiihonen; Qian Zhao; C Ryan Campbell; Elizabeth T Cirulli; Dongliang Ge; Massimo Gennarelli; Curtis Gumbs; Tero Hallikainen; Min He; Erin L Heinzen; Linda Hong; Deborah L Levy; Jessica M Maia; Joseph P McEvoy; Herbert Y Meltzer; David B Goldstein
Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia.
American journal of human genetics 2012;91(2):303-12.
2012: E J Brandl; S Büttner; S Ehrlich; C Frydrychowicz; James L Kennedy; W Kitzrow; T A P Lett; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller; A K Tiwari; Imke Puls
Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
Progress in neuro-psychopharmacology & biological psychiatry 2012;38(2):134-41.
2012: Jingchun Sun; Zhongming Zhao; Karu Jayathilake; Herbert Y Meltzer
Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia.
Psychiatry research 2012;198(2):202-6.
2012: Yuko Hirata; Jeffrey A Lieberman; Herbert Y Meltzer; Renan Souza; Clement Zai; James L Kennedy
Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies.
Human psychopharmacology 2012;27(4):345-51.
2012: Jason M Wiebelhaus; Sarah A Vunck; Herbert Y Meltzer; Joseph H Porter
Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice.
Behavioural pharmacology 2012;23(3):262-70.
2012: Arun K Tiwari; A N Voineskos; Clement Zai; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; Daniel J Müller; Steven G Potkin; Gary Remington; James L Kennedy
Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
The pharmacogenomics journal 2012;12(3):260-6.
2012: M Horiguchi; Herbert Y Meltzer
The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.
Psychopharmacology 2012;221(2):205-15.
2012: Rudi Hwang; Daniel Felsky; Jeffrey A Lieberman; Herbert Y Meltzer; Gabriel Oh; Steven G Potkin; Eli Remington; Renan Souza; Arun K Tiwari; Ryan P Tong; Tessa Wallace; Clement Zai; James L Kennedy
Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.
Progress in neuro-psychopharmacology & biological psychiatry 2012;37(1):62-75.
2012: Renan Souza; Arun K Tiwari; Rolando B Ceddia; Nabilah I Chowdhury; James L Kennedy; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel J Müller
Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
Journal of psychiatric research 2012;46(4):462-8.
2012: Daniel J Müller; E Remington; S Shaikh; M Sicard; Renan Souza; Arun K Tiwari; Clement Zai; Tamara Arenovich; N Freeman; A Heinz; Rudi Hwang; Jeffrey A Lieberman; Olga Likhodi; Herbert Y Meltzer; James L Kennedy
Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.
The pharmacogenomics journal 2012;12(2):156-64.
2012: Herbert Y Meltzer
Serotonergic mechanisms as targets for existing and novel antipsychotics.
Handbook of experimental pharmacology 2012;(212):87-124.
2012: Qian Liu; Bill W Massey; Herbert Y Meltzer; Saranya Padmanabhan; Timothy L Ramsey; Mark D Brennan
Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia.
The primary care companion to CNS disorders 2012;14(3):.
2011: Tristram A P Lett; Jeffrey A Lieberman; Herbert Y Meltzer; Steven G Potkin; Arun K Tiwari; Aristotle N Voineskos; James L Kennedy; Daniel J Müller
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
Schizophrenia research 2011;132(2-3):121-4.
2011: Jason M Wiebelhaus; Kevin A Webster; Herbert Y Meltzer; Joseph H Porter
The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice.
Behavioural pharmacology 2011;22(5-6):458-67.
2011: Masakuni Horiguchi; Mei Huang; Herbert Y Meltzer
Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.
Psychopharmacology 2011;217(1):13-24.
2011: William V Bobo; Karu Jayathilake; Min Young Sim; Neil D Woodward; Herbert Y Meltzer
The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial.
Schizophrenia research 2011;130(1-3):106-13.
2011: Peilin Jia; Karu Jayathilake; Zhongming Zhao; Herbert Y Meltzer
Association of FAS, a TNF-α receptor gene, with treatment resistant schizophrenia.
Schizophrenia research 2011;129(2-3):211-2.
2011: Peilin Jia; Lily Wang; Herbert Y Meltzer; Zhongming Zhao
Pathway-based analysis of GWAS datasets: effective but caution required.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011;14(4):567-72.
2011: Renan Souza; Daniela V F Rosa; Marco A Romano-Silva; Mei Zhen; Herbert Y Meltzer; Jeffrey A Lieberman; Gary Remington; James L Kennedy; Albert H C Wong
Lack of association of NALCN genetic variants with schizophrenia.
Psychiatry research 2011;185(3):450-2.
2011: Herbert Y Meltzer; Masakuni Horiguchi; Bill Massey
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.
Psychopharmacology 2011;213(2-3):289-305.
2011: Aygün Ertuğrul; Hatice Ozdemir; Atay Vural; Turgay Dalkara; Herbert Y Meltzer; Esen Saka
The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus.
Brain research bulletin 2011;84(2):144-50.
2011: Renan Souza; Aristotle N Voineskos; Jeffrey A Lieberman; Herbert Y Meltzer; Gary Remington; James L Kennedy
Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.
Human psychopharmacology 2011;26(1):21-7.
2010: Arun K Tiwari; Jarlath B Rodgers; Michelle Sicard; Clement Zai; Olga Likhodi; Natalie Freeman; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy; Daniel J Müller
Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(8):1484-90.
2010: Clement Zai; Mirko Manchia; Vincenzo De Luca; Arun K Tiwari; Alessio Squassina; Gwyneth Zai; John Strauss; Sajid A Shaikh; Natalie Freeman; Herbert Y Meltzer; Jeffrey Lieberman; Bernard Le Foll; James L Kennedy
Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(8):1412-8.
2010: Renan Souza; Herbert Y Meltzer; Jeffrey A Lieberman; Bernard Le Foll; James L Kennedy
Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
Human psychopharmacology 2010;25(7-8):582-5.
2010: Gabriela Novak; Clement Zai; M Mirkhani; Sajid Shaikh; John B Vincent; Herbert Y Meltzer; Jeffrey A Lieberman; John Strauss; D Lévesque; James L Kennedy; Bernard Le Foll
Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.
Genes, brain, and behavior 2010;9(8):910-7.
2010: Renan Souza; Gary Remington; Nabilah I Chowdhury; Matthew K Lau; Aristotle N Voineskos; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(10):688-94.
2010: Peilin Jia; Lily Wang; Herbert Y Meltzer; Zhongming Zhao
Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data.
Schizophrenia research 2010;122(1-3):38-42.
2010: Clement Zai; Arun K Tiwari; Daniel J Müller; Vincenzo De Luca; Takahiro Shinkai; Sajid Shaikh; Xingqun Ni; David Sibony; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
The catechol-O-methyl-transferase gene in tardive dyskinesia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(6):803-12.
2010: Renan Souza; Plabon Ismail; Herbert Y Meltzer; James L Kennedy
Variants in the oxytocin gene and risk for schizophrenia.
Schizophrenia research 2010;121(1-3):279-80.
2010: Renan Souza; Vincenzo De Luca; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy
Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(6):793-8.
2010: Renan Souza; Vincenzo De Luca; Gary Remington; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy; Albert H C Wong
Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.
Psychopharmacology 2010;210(3):347-54.
2010: Rudi Hwang; Clement Zai; Arun K Tiwari; Daniel J Müller; Maria J Arranz; A G Morris; P J McKenna; J Munro; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant.
The pharmacogenomics journal 2010;10(3):200-18.
2010: Herbert Y Meltzer; William V Bobo; Myung A Lee; Philip Cola; Karu Jayathilake
A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
Psychiatry research 2010;177(3):286-93.
2010: Arun K Tiwari; Clement Zai; Olga Likhodi; Annika Lisker; Deepika Singh; Renan Souza; Poonam Batra; Syed Zaidi; Sheng Chen; Fang Liu; Imke Puls; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy; Daniel J Müller
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(6):1315-24.
2010: Xiao-Ming Ou; Craig A Stockmeier; Herbert Y Meltzer; James C Overholser; George J Jurjus; Lesa Dieter; Kevin Chen; Deyin Lu; Chandra Johnson; Moussa B H Youdim; Mark C Austin; Jia Luo; Akira Sawa; Warren May; Jean C Shih
A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage.
Biological psychiatry 2010;67(9):855-63.
2010: Arun K Tiwari; Clement C Zai; Herbert Y Meltzer; Jeffrey A Lieberman; Daniel J Müller; James L Kennedy
Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
Human psychopharmacology 2010;25(3):253-9.
2010: Herbert Y Meltzer; Roger Mills; Stephen Revell; Hilde Williams; Ann Johnson; Daun Bahr; Joseph H Friedman
Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(4):881-92.
2010: Gabriela Novak; Alexandra Gallo; Clement Zai; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Aristotle N Voineskos; Gary Remington; James L Kennedy; Daniel Levesque; Bernard Le Foll
Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
Psychiatric genetics 2010;20(1):39-43.
2010: Clement Zai; Arun K Tiwari; Vincenzo S Basile; Vincenzo De Luca; Daniel J Müller; Aristotle N Voineskos; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(1):50-6.
2009: Renan Souza; Maria Tampakeras; Vincenzo S Basile; Takahiro Shinkai; Daniela V F Rosa; Steve Potkin; Herbert Y Meltzer; Jeffrey A Lieberman; Marco A Romano-Silva; James L Kennedy
Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects.
Human psychopharmacology 2009;24(8):676-9.
2009: Herbert Y Meltzer; Argyris Dritselis; Uma Yasothan; Peter Kirkpatrick
Asenapine.
Nature reviews. Drug discovery 2009;8(11):843-4.
2009: Paul E Bebbington; Claudia Cooper; Sarah Minot; Traolach S Brugha; Rachel Jenkins; Herbert Y Meltzer; Michael Dennis
Suicide attempts, gender, and sexual abuse: data from the 2000 British Psychiatric Morbidity Survey.
The American journal of psychiatry 2009;166(10):1135-40.
2009: Clement Zai; Arun K Tiwari; Nicole King; Vincenzo De Luca; Daniel J Mueller; Sajid Shaikh; Gregory W H Wong; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy
Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.
Schizophrenia research 2009;114(1-3):33-8.
2009: Yasuhiro Kaneda; Karuna Jayathilak; Herbert Y Meltzer
Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
Psychiatry research 2009;169(2):178-9.
2009: David Meltzer; Anirban Basu; Herbert Y Meltzer
Comparative effectiveness research for antipsychotic medications: how much is enough?
Health affairs (Project Hope) 2009;28(5):w794-808.
2009: Zhu Li; Adam J Prus; Jin Dai; Herbert Y Meltzer
Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
The Journal of pharmacology and experimental therapeutics 2009;330(3):948-55.
2009: Laertes Sickert; Daniel J Müller; Arun K Tiwari; Sajid Shaikh; Clement Zai; Renan Souza; Vincenzo De Luca; Herbert Y Meltzer; Jeffrey A Lieberman; James L Kennedy
Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.
Pharmacogenomics 2009;10(7):1169-76.
2009: William V Bobo; Karu Jayathilake; Myung A Lee; Herbert Y Meltzer
Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Human psychopharmacology 2009;24(5):415-22.
2009: Atheir I Abbas; Peter B Hedlund; Xi-Ping Huang; Thuy B Tran; Herbert Y Meltzer; Bryan L Roth
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.
Psychopharmacology 2009;205(1):119-28.
2009: Robert M Kessler; Neil D Woodward; Patrizia Riccardi; Rui Li; Mohammad Sib Ansari; Sharlett Anderson; Benoit M Dawant; David H Zald; Herbert Y Meltzer
Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.
Biological psychiatry 2009;65(12):1024-31.
2009: Clement Zai; Arun K Tiwari; Vincenzo S Basile; Vincenzo De Luca; Daniel J Müller; Nicole King; A N Voineskos; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
The pharmacogenomics journal 2009;9(3):168-74.
2009: Vincenzo De Luca; Renan Souza; Emanuella Viggiano; Clement Zai; Takahiro Shinkai; Jeffrey A Lieberman; Steven G Potkin; Herbert Y Meltzer; Gary Remington; James L Kennedy
MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis.
Schizophrenia research 2009;110(1-3):200-1.
2009: Clement Zai; Arun K Tiwari; Vincenzo De Luca; Daniel J Müller; Natalie Bulgin; Rudi Hwang; Gwyneth C Zai; Nicole King; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(5):317-28.
2009: Scott D Philibin; D Matthew Walentiny; Sarah A Vunck; Adam J Prus; Herbert Y Meltzer; Joseph H Porter
Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism.
Psychopharmacology 2009;203(2):303-15.
2009: Herbert Y Meltzer
Atypical antipsychotic drugs have their merits.
Lancet 2009;373(9668):1007; author reply 1007-8.
2009: Bernadeta Szewczyk; Paul R Albert; Ariel M Burns; Margaret Czesak; James C Overholser; George J Jurjus; Herbert Y Meltzer; Lisa C Konick; Lesa Dieter; Nicole Herbst; Warren May; Grazyna Rajkowska; Craig A Stockmeier; Mark C Austin
Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(2):155-68.
2009: Anna C Need; Dongliang Ge; Michael E Weale; Jessica Maia; Sheng Feng; Erin L Heinzen; Kevin V Shianna; Woohyun Yoon; Dalia Kasperaviciūte; Massimo Gennarelli; Warren J Strittmatter; Cristian Bonvicini; Giuseppe Rossi; Karu Jayathilake; Philip A Cola; Joseph P McEvoy; Richard S E Keefe; Elizabeth M C Fisher; Pamela L St Jean; Ina Giegling; Annette M Hartmann; Hans-Jürgen Möller; Andreas Ruppert; Gillian Fraser; Caroline Crombie; Lefkos T Middleton; David St Clair; Allen D Roses; Pierandrea Muglia; Clyde Francks; Dan Rujescu; Herbert Y Meltzer; David B Goldstein
A genome-wide investigation of SNPs and CNVs in schizophrenia.
PLoS genetics 2009;5(2):e1000373.
2009: Yona Geffen; Abraham Nudelman; Irit Gil-Ad; Ada Rephaeli; Mei Huang; Kinneret Savitsky; Leah Klapper; Ilan Winkler; Herbert Y Meltzer; Abraham Weizman
BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(1):1-13.
2008: Herbert Y Meltzer; Tomiki Sumiyoshi
Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?
Behavioural brain research 2008;195(1):98-102.
2008: Clement Zai; Marco A Romano-Silva; Rudi Hwang; Gwyneth C Zai; Vincenzo Deluca; Daniel J Müller; Nicole King; Aristotle N Voineskos; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gary Remington; James L Kennedy
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
Schizophrenia research 2008;106(2-3):248-52.
2008: Herbert Y Meltzer; Mark D Brennan; Neil D Woodward; Karu Jayathilake
Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder.
Schizophrenia research 2008;106(2-3):258-64.
2008: Mei Huang; Zhu Li; Jin Dai; Mohammed Shahid; Erik H F Wong; Herbert Y Meltzer
Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(12):2934-45.
2008: Zhu Li; Shikha Snigdha; Alex S Roseman; Jin Dai; Herbert Y Meltzer
Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.
European journal of pharmacology 2008;596(1-3):89-97.
2008: David W Ayer; Karu Jayathilake; Herbert Y Meltzer
The InterSePT suicide scale for prediction of imminent suicidal behaviors.
Psychiatry research 2008;161(1):87-96.
2008: Herbert Y Meltzer
Oakley Ray, 1931-2007.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(11):2783-4.
2008: Renan Souza; Marco Romano-Silva; Jeffrey A Lieberman; Herbert Y Meltzer; Albert H C Wong; James L Kennedy
Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.
Psychopharmacology 2008;200(2):177-86.
2008: Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.
Pharmacological reviews 2008;60(3):358-403.
2008: Bruce J Kinon; Jan Volavka; Virginia Stauffer; Sara E Edwards; Hong Liu-Seifert; Lei Chen; David H Adams; Jean-Pierre Lindenmayer; Joseph P McEvoy; Peter F Buckley; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel R. Wilson; Leslie Citrome
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.
Journal of clinical psychopharmacology 2008;28(4):392-400.
2008: Herbert Y Meltzer; William V Bobo; Isaac F Nuamah; Rosanne Lane; David Hough; Michelle Kramer; Marielle Eerdekens
Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies.
The Journal of clinical psychiatry 2008;69(5):817-29.
2008: Richard S E Keefe; Anil Malhotra; Herbert Y Meltzer; John M Kane; Robert W Buchanan; Anita Murthy; Mindy Sovel; Chunming Li; Robert Goldman
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(6):1217-28.
2008: John H Krystal; Cameron S Carter; Daniel Geschwind; Husseini K Manji; John March; Eric J Nestler; Jon K Zubieta; Dennis S Charney; David Goldman; Raquel E Gur; Jeffrey A Lieberman; Peter Roy-Byrne; David Rubinow; Stewart A Anderson; Samuel Barondes; Karen F Berman; James Blair; David L Braff; E Sherwood Brown; Joseph Calabrese; William A Carlezon; Edwin H Cook; Richard Davidson; Michael Davis; Robert Desimone; Wayne C Drevets; Ronald S Duman; Susan M Essock; Stephen Faraone; Robert Freedman; Karl J Friston; Joel Gelernter; Barbara Geller; Michael Gill; Elizabeth Gould; Anthony A Grace; Christian Grillon; Ralitza Gueorguieva; Ahmad R Hariri; Robert B Innis; Edward G Jones; Joel E Kleinman; George F Koob; Andrew D Krystal; Ellen Leibenluft; Douglas F Levinson; Pat Levitt; David A Lewis; Israel Liberzon; Barbara K Lipska; Stephen R Marder; Athina Markou; Graeme F Mason; Christopher J McDougle; Bruce McEwen; Francis McMajon; Michael J Meaney; Herbert Y Meltzer; Kathleen Ries Merikangas; Andreas Meyer-Lindenberg; Károly Mirnics; Lisa M Monteggia; Alexander Neumeister; Charles P O'Brien; Michael J Owen; Daniel S Pine; Judy Rapoport; Scott L Rauch; Trevor W Robbins; Jerrold F Rosenbaum; David R Rosenberg; Christopher A Ross; john rush; Harold A Sackeim; Gerard Sanacora; Alan F Schatzberg; Yavin Shaham; Larry J Siever; Trey Sunderland; Laurence H Tecott; Michael E Thase; Richard D Todd; Myrna M Weissman; Rachel Yehuda; Takeo Yoshikawa; Elizabeth A Young; R McCandless
It is time to take a stand for medical research and against terrorism targeting medical scientists.
Biological psychiatry 2008;63(8):725-7.
2008: Herbert Y Meltzer; William V Bobo; Ajanta Roy; Karu Jayathilake; Yuejin Chen; Aygun Ertugrul; A Elif Anil Yağcioğlu; Joyce G Small
A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
The Journal of clinical psychiatry 2008;69(2):274-85.
2008: Herbert Y Meltzer; Mei Huang
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Progress in brain research 2008;172():177-97.
2007: Adam J Prus; Mei Huang; Zhu Li; Jin Dai; Herbert Y Meltzer
The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Brain research 2007;1184():354-64.
2007: J Renou; Vincenzo De Luca; Clement Zai; Natalie Bulgin; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; B Le Foll; James L Kennedy
Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia.
Molecular psychiatry 2007;12(12):1058-60.
2007: Tamsin Ford; Stephan Collishaw; Herbert Y Meltzer; Robert Goodman
A prospective study of childhood psychopathology: independent predictors of change over three years.
Social psychiatry and psychiatric epidemiology 2007;42(12):953-61.
2007: Hyo Jung Kang; David H Adams; Arthur A Simen; Birgitte Simen; Grazyna Rajkowska; Craig A Stockmeier; James C Overholser; Herbert Y Meltzer; George J Jurjus; Lisa C Konick; Samuel S Newton; Ronald S Duman
Gene expression profiling in postmortem prefrontal cortex of major depressive disorder.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(48):13329-40.
2007: Zhu Li; Douglas W Bonhaus; Mei Huang; Adam J Prus; Jin Dai; Herbert Y Meltzer
AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.
European journal of pharmacology 2007;572(2-3):129-37.
2007: Helio Elkis; Herbert Y Meltzer
[Refractory schizophrenia].
Revista brasileira de psiquiatria (São Paulo, Brazil : 1999) 2007;29 Suppl 2():S41-7.
2007: Vincenzo De Luca; Daniel J Müller; Rudi Hwang; Jeffrey A Lieberman; Jan Volavka; Herbert Y Meltzer; James L Kennedy
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
Human psychopharmacology 2007;22(7):463-7.
2007: Clement Zai; Rudi Hwang; Vincenzo De Luca; Daniel J Müller; Nicole King; Gwyneth C Zai; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; James L Kennedy
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(5):639-51.
2007: A Carlo Altamura; William V Bobo; Herbert Y Meltzer
Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
International clinical psychopharmacology 2007;22(5):249-67.
2007: Tomiki Sumiyoshi; Sohee Park; Karu Jayathilake; Ajanta Roy; Aygun Ertugrul; Herbert Y Meltzer
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
Schizophrenia research 2007;95(1-3):158-68.
2007: Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Xingqun Ni; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.
Journal of psychopharmacology (Oxford, England) 2007;21(7):718-27.
2007: Richard S E Keefe; Robert Bilder; Sonia M Davis; Philip D Harvey; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; George Capuano; Thomas Stroup; Joseph P McEvoy; Marvin Swartz; Robert A Rosenheck; Diana O Perkins; Clarence E Davis; John K Hsiao; Jeffrey A Lieberman
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Archives of general psychiatry 2007;64(6):633-47.
2007: Tomiki Sumiyoshi; Yuko Higuchi; Mié Matsui; Hirofumi Arai; Chieko Takamiya; Herbert Y Meltzer; Masayoshi Kurachi
Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(4):965-7.
2007: Herbert Y Meltzer
Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3019-20.
2007: Zhu Li; Mei Huang; Adam J Prus; Jin Dai; Herbert Y Meltzer
5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Brain research 2007;1134(1):70-8.
2007: John M Kane; Herbert Y Meltzer; William H Carson; Robert D McQuade; Ronald N Marcus; Raymond Sanchez
Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
The Journal of clinical psychiatry 2007;68(2):213-23.
2007: Neil D Woodward; Karu Jayathilake; Herbert Y Meltzer
COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
Schizophrenia research 2007;90(1-3):86-96.
2007: Maurizio Pompili; Xavier F Amador; Paolo Girardi; Jill Harkavy-Friedman; Martin Harrow; Kalman J Kaplan; Michael Krausz; David Lester; Herbert Y Meltzer; Jiri Modestin; Lori P Montross; Preben Bo Mortensen; Povl Munk-Jørgensen; Jimmi Nielsen; Merete Nordentoft; Pirjo Irmeli Saarinen; Sidney Zisook; Scott Wilson; Roberto Tatarelli
Suicide risk in schizophrenia: learning from the past to change the future.
Annals of general psychiatry 2007;6():10.
2007: A Carlo Altamura; Emanuela Mundo; Roberta Bassetti; A Green; Jean-Pierre Lindenmayer; Larry Alphs; Herbert Y Meltzer
Transcultural differences in suicide attempters: analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder.
Schizophrenia research 2007;89(1-3):140-6.
2007: Neil D Woodward; Scot E Purdon; Herbert Y Meltzer; David H Zald
A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.
Schizophrenia research 2007;89(1-3):211-24.
2007: Karen L Marquis; Annmarie L Sabb; Sheree F Logue; Julie A Brennan; Michael J Piesla; thomas Comery; Steven M Grauer; Charles R Ashby; Huy Q Nguyen; Lee A Dawson; James E Barrett; Gary Stack; Herbert Y Meltzer; Boyd L Harrison; Sharon Rosenzweig-Lipson
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
The Journal of pharmacology and experimental therapeutics 2007;320(1):486-96.
2007: Andrew C McCreary; Jeffrey C Glennon; Charles R Ashby; Herbert Y Meltzer; Zhu Li; Jan-Hendrik Reinders; Mayke B Hesselink; Stephen K Long; Arnoud H J Herremans; Herman H van Stuivenberg; Rolf W Feenstra; Chris G Kruse
SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(1):78-94.
2006: Berna Binnur Kivircik Akdede; A Elif Anil Yağcioğlu; Köksal Alptekin; Tolga I Turgut; Mevhibe Tümüklü; M Kâzim Yazici; Karu Jayathilake; Zeliha Tunca; Ahmet Göğüş; Herbert Y Meltzer
A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
The Journal of clinical psychiatry 2006;67(12):1912-9.
2006: Chika Sumiyoshi; Tomiki Sumiyoshi; Ajanta Roy; Karu Jayathilake; Herbert Y Meltzer
Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(6):677-83.
2006: Jose Javier Miguel-Hidalgo; James C Overholser; Herbert Y Meltzer; Craig A Stockmeier; Grazyna Rajkowska
Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence.
Alcoholism, clinical and experimental research 2006;30(11):1845-55.
2006: Gwyneth Zai; Daniel J Müller; Jan Volavka; Pal Czobor; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.
Psychopharmacology 2006;188(2):171-82.
2006: Anirban Basu; Herbert Y Meltzer; Vanja Dukic
Estimating transitions between symptom severity states over time in schizophrenia: a Bayesian meta-analytic approach.
Statistics in medicine 2006;25(17):2886-910.
2006: Anirban Basu; Herbert Y Meltzer
Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era.
Schizophrenia research 2006;86(1-3):99-109.
2006: Robert M Kessler; Mohammad Sib Ansari; Patrizia Riccardi; Rui Li; Karu Jayathilake; Benoit M Dawant; Herbert Y Meltzer
Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1991-2001.
2006: Richard S E Keefe; Robert Bilder; Philip D Harvey; Sonia M Davis; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; Del D Miller; Jose M Canive; Lawrence W Adler; Theo C Manschreck; Marvin Swartz; Robert Rosenheck; Diana O Perkins; Trina M Walker; Thomas Stroup; Joseph P McEvoy; Jeffrey A Lieberman
Baseline neurocognitive deficits in the CATIE schizophrenia trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):2033-46.
2006: Mei Huang; Zhu Li; Junji Ichikawa; Jin Dai; Herbert Y Meltzer
Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Brain research 2006;1099(1):44-55.
2006: Herbert Y Meltzer; William V Bobo
Interpreting the efficacy findings in the CATIE study: what clinicians should know.
CNS spectrums 2006;11(7 Suppl 7):14-24.
2006: Rudi Hwang; Takahiro Shinkai; Vincenzo Deluca; Fabio Macciardi; Steven G Potkin; Herbert Y Meltzer; James L Kennedy
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(4):248-59.
2006: Herbert Y Meltzer; A Elif Anil Yağcioğlu; Berna Binnur Kivircik Akdede
Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
The New England journal of medicine 2006;354(17):1846-8; author reply 1846-8.
2006: Joseph P McEvoy; Jeffrey A Lieberman; Thomas Stroup; Sonia M Davis; Herbert Y Meltzer; Robert A Rosenheck; Marvin Swartz; Diana O Perkins; Richard S E Keefe; Clarence E Davis; Joanne B Severe; John K Hsiao
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
The American journal of psychiatry 2006;163(4):600-10.
2006: Mei Huang; Junji Ichiwaka; Zhu Li; Jin Dai; Herbert Y Meltzer
Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.
Psychopharmacology 2006;185(3):274-81.
2006: J John Mann; Graham J Emslie; Ross J Baldessarini; William Beardslee; Jan A Fawcett; Frederick K Goodwin; Andrew C Leon; Herbert Y Meltzer; Neal D Ryan; David Shaffer; Karen D Wagner
ACNP Task Force report on SSRIs and suicidal behavior in youth.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(3):473-92.
2006: Takahiro Shinkai; Daniel J Müller; Vincenzo De Luca; Sajid Shaikh; Chima Matsumoto; Rudi Hwang; Nicole King; Joseph Trakalo; Natalia Potapova; Gwyneth Zai; Hiroko Hori; Osamu Ohmori; Herbert Y Meltzer; Jun Nakamura; James L Kennedy
Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesia.
Psychiatry research 2006;141(2):123-8.
2005: Will Spooren; Claus Riemer; Herbert Y Meltzer
Opinion: NK3 receptor antagonists: the next generation of antipsychotics?
Nature reviews. Drug discovery 2005;4(12):967-75.
2005: Zhu Li; Junji Ichikawa; Mei Huang; Adam J Prus; Jin Dai; Herbert Y Meltzer
ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Psychopharmacology 2005;183(2):144-53.
2005: Joseph P McEvoy; Jonathan M Meyer; Donald C Goff; Henry A Nasrallah; Sonia M Davis; Lisa Sullivan; Herbert Y Meltzer; John K Hsiao; T Scott Stroup; Jeffrey A Lieberman
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.
Schizophrenia research 2005;80(1):19-32.
2005: Robert M Kessler; Mohammad Sib Ansari; Patrizia Riccardi; Rui Li; Karu Jayathilake; Benoit M Dawant; Herbert Y Meltzer
Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(12):2283-9.
2005: Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Chima Matsumoto; Hiroko Hori; Osamu Ohmori; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Jun Nakamura; James L Kennedy
Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
Neuroscience letters 2005;388(2):116-20.
2005: Zhu Li; Mei Huang; Junji Ichikawa; Jin Dai; Herbert Y Meltzer
N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(11):1986-95.
2005: Daniel J Müller; Vincenzo De Luca; Tricia Sicard; Nicole King; Rudi Hwang; Jan Volavka; Pal Czobor; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):525-31.
2005: Bernard Lerer; Ronnen Segman; Ene-Choo Tan; Vincenzo S Basile; Roberto Cavallaro; Harald N Aschauer; Rael D Strous; Siow-Ann Chong; Uriel Heresco-Levy; Massimiliano Verga; Joachim Scharfetter; Herbert Y Meltzer; James L Kennedy; Fabio Macciardi
Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):411-25.
2005: Tomiki Sumiyoshi; Dai Jin; Karu Jayathilake; Myung Lee; Herbert Y Meltzer
Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):451-5.
2005: Neil D Woodward; Scot E Purdon; Herbert Y Meltzer; David H Zald
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):457-72.
2005: Junji Ichikawa; Young-Chul Chung; Jin Dai; Herbert Y Meltzer
Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release.
Brain research 2005;1052(1):56-62.
2005: Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Daniel J Müller; Xingqun Ni; Fabio Macciardi; Steven G Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.
Psychopharmacology 2005;181(1):179-87.
2005: Cicely Marston; Herbert Y Meltzer; Azeem Majeed
Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys.
BMJ (Clinical research ed.) 2005;331(7511):271.
2005: Junji Ichikawa; Jin Dai; Herbert Y Meltzer
Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
Brain research 2005;1049(2):182-90.
2005: Arthur Crisp; Michael Gelder; Eileen Goddard; Herbert Y Meltzer
Stigmatization of people with mental illnesses: a follow-up study within the Changing Minds campaign of the Royal College of Psychiatrists.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2005;4(2):106-13.
2005: Herbert Y Meltzer
Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(2):153-6.
2005: Michael F Green; Thomas R E Barnes; Jean-Marie Danion; Bernd Gallhofer; Herbert Y Meltzer; Christos Pantelis
The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia.
Schizophrenia research 2005;74(2-3):253-61.
2005: Herbert Y Meltzer
Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.
The Journal of clinical psychiatry 2005;66(4):530-3.
2005: Marilyn A Davies; Beth A Compton-Toth; Sandra J Hufeisen; Herbert Y Meltzer; Bryan L Roth
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?
Psychopharmacology 2005;178(4):451-60.
2005: A Elif Anil Yağcioğlu; Berna B Kivircik Akdede; Tolga I Turgut; Mevhibe Tümüklü; M Kâzim Yazici; Köksal Alptekin; Aygün Ertuğrul; Karu Jayathilake; Ahmet Göğüş; Zeliha Tunca; Herbert Y Meltzer
A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
The Journal of clinical psychiatry 2005;66(1):63-72.
2004: David M Weiner; Herbert Y Meltzer; isaac veinbergs; E M Donohue; Tracy A Spalding; T T Smith; Nina Mohell; Scott C Harvey; Jelveh Lameh; Norman R Nash; Kimberly E Vanover; Roger Olsson; K Jayathilake; Michael K Lee; Allan Levey; Uli Hacksell; Ethan S Burstein; Robert E Davis; Mark R Brann
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.
Psychopharmacology 2004;177(1-2):207-16.
2004: Tomiki Sumiyoshi; A Roy; C-H Kim; Karu Jayathilake; M A Lee; Chika Sumiyoshi; Herbert Y Meltzer
Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia.
Psychopharmacology 2004;177(1-2):79-83.
2004: Craig A Stockmeier; Gouri J Mahajan; Lisa C Konick; James C Overholser; George J Jurjus; Herbert Y Meltzer; Harry Uylings; Lee Friedman; Grazyna Rajkowska
Cellular changes in the postmortem hippocampus in major depression.
Biological psychiatry 2004;56(9):640-50.
2004: Young-Chul Chung; Zhu Li; Jin Dai; Herbert Y Meltzer; Junji Ichikawa
Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.
Brain research 2004;1023(1):54-63.
2004: Herbert Y Meltzer
Cognitive factors in schizophrenia: causes, impact, and treatment.
CNS spectrums 2004;9(10 Suppl 11):15-24.
2004: Susan R McGurk; Kim T Mueser; David Walling; Philip D Harvey; Herbert Y Meltzer
Cognitive functioning predicts outpatient service utilization in schizophrenia.
Mental health services research 2004;6(3):185-8.
2004: Aygun Ertugrul; James L Kennedy; Mario Masellis; Vincenzo S Basile; Karu Jayathilake; Herbert Y Meltzer
No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia.
Schizophrenia research 2004;69(2-3):301-5.
2004: Tomiki Sumiyoshi; Herbert Y Meltzer
Serotonin 1A receptors in memory function.
The American journal of psychiatry 2004;161(8):1505; author reply 1505-6.
2004: Marc Bourgeois; Joel D Swendsen; Frederick Young; Xavier F Amador; Stefano Pini; Giovanni B Cassano; Jean-Pierre Lindenmayer; Chuanchieh Hsu; Larry Alphs; Herbert Y Meltzer
Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial.
The American journal of psychiatry 2004;161(8):1494-6.
2004: Tomiki Sumiyoshi; Ajanta Roy; Karu Jayathilake; Herbert Y Meltzer
The effect of hypertension and obesity on the development of diabetes mellitus in patients treated with atypical antipsychotic drugs.
Journal of clinical psychopharmacology 2004;24(4):452-4.
2004: Zhu Li; Junji Ichikawa; Jin Dai; Herbert Y Meltzer
Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
European journal of pharmacology 2004;493(1-3):75-83.
2004: Herbert Y Meltzer; Lisa Arvanitis; Deborah Bauer; Werner Rein
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
The American journal of psychiatry 2004;161(6):975-84.
2004: Tomiki Sumiyoshi; Ajanta Roy; A Elif Anil; Karu Jayathilake; Aygun Ertugrul; Herbert Y Meltzer
A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine.
Journal of clinical psychopharmacology 2004;24(3):345-8.
2004: george jaskiw; Ghazala Hussain; Stacy E Stephans; Bryan K Yamamoto; Herbert Y Meltzer
Clozapine prolongs hypotonic immobility in rats with bilateral 6-hydroxydopamine lesions of the striatum.
Neuroscience letters 2004;362(1):35-8.
2004: Tomiki Sumiyoshi; A Elif Anil; Dai Jin; Karu Jayathilake; Myung Lee; Herbert Y Meltzer
Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(1):1-8.
2004: Philip D Harvey; Herbert Y Meltzer; George M Simpson; Steven G Potkin; Antony Loebel; Cynthia O Siu; Steven J Romano
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.
Schizophrenia research 2004;66(2-3):101-13.
2004: Herbert Y Meltzer
What's atypical about atypical antipsychotic drugs?
Current opinion in pharmacology 2004;4(1):53-7.
2004: Adam J Prus; Lisa E Baker; Herbert Y Meltzer
Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
Pharmacology, biochemistry, and behavior 2004;77(2):199-208.
2004: Larry Alphs; Ravi Anand; M Zahur Islam; Herbert Y Meltzer; John M Kane; Ranga Krishnan; Alan I Green; Steven G Potkin; Guy Chouinard; Jean-Pierre Lindenmayer; Rob Kerwin
The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients.
Schizophrenia bulletin 2004;30(3):577-86.
2004: Susan R McGurk; M A Lee; K Jayathilake; Herbert Y Meltzer
Cognitive effects of olanzapine treatment in schizophrenia.
MedGenMed : Medscape general medicine 2004;6(2):27.
2003: Herbert Y Meltzer
Beyond control of acute exacerbation: enhancing affective and cognitive outcomes.
CNS spectrums 2003;8(11 Suppl 2):16-8, 22.
2003: Stefania Bonaccorso; Steven F Maier; Herbert Y Meltzer; Michael Maes
Behavioral changes in rats after acute, chronic and repeated administration of interleukin-1beta: relevance for affective disorders.
Journal of affective disorders 2003;77(2):143-8.
2003: Herbert Y Meltzer; Zhu Li; Yasuhiro Kaneda; Junji Ichikawa
Serotonin receptors: their key role in drugs to treat schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(7):1159-72.
2003: Herbert Y Meltzer; Ross J Baldessarini
Reducing the risk for suicide in schizophrenia and affective disorders.
The Journal of clinical psychiatry 2003;64(9):1122-9.
2003: Aygun Ertugrul; Herbert Y Meltzer
Antipsychotic drugs in bipolar disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(3):277-84.
2003: Philip D Harvey; Michael F Green; Susan R McGurk; Herbert Y Meltzer
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.
Psychopharmacology 2003;169(3-4):404-11.
2003: Steven G Potkin; Larry Alphs; Chuanchieh Hsu; K Ranga Rama Krishnan; Ravi Anand; Frederick K Young; Herbert Y Meltzer; Alan Green
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.
Biological psychiatry 2003;54(4):444-52.
2003: george jaskiw; Tim E Blumer; Rolando Gutierrez-Esteinou; Herbert Y Meltzer; Vickie Steele; Milton E Strauss
Comparison of inpatients with major mental illness who do and do not consent to low-risk research.
Psychiatry research 2003;119(1-2):183-8.
2003: David M Weiner; Kimberly E Vanover; Mark R Brann; Herbert Y Meltzer; Robert E Davis
Psychosis of Parkinson's disease: serotonin 2A receptor inverse agonists as potential therapeutics.
Current opinion in investigational drugs (London, England : 2000) 2003;4(7):815-9.
2003: Tomiki Sumiyoshi; Karu Jayathilake; Herbert Y Meltzer
A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
Schizophrenia research 2003;62(1-2):65-72.
2003: Toshihide Kuroki; Herbert Y Meltzer; Junji Ichikawa
5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Brain research 2003;972(1-2):216-21.
2003: Zhu Li; Chan H Kim; Junji Ichikawa; Herbert Y Meltzer
Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice.
Pharmacology, biochemistry, and behavior 2003;75(2):335-40.
2003: Zhu Li; Junji Ichikawa; Herbert Y Meltzer
A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.
Psychopharmacology 2003;167(3):315-23.
2003: Wesley K Kroeze; Sandra J Hufeisen; Beth A Popadak; Sean Renock; SeAnna Steinberg; Paul Ernsberger; Karu Jayathilake; Herbert Y Meltzer; Bryan L Roth
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(3):519-26.
2003: Chan-Hyung Kim; Karu Jayathilake; Herbert Y Meltzer
Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior.
Schizophrenia research 2003;60(1):71-80.
2003: Herbert Y Meltzer; Tomiki Sumiyoshi
Atypical antipsychotic drugs improve cognition in schizophrenia.
Biological psychiatry 2003;53(3):265-7; author reply 267-8.
2003: Richard S E Keefe; Richard C Mohs; Robert Bilder; Philip D Harvey; Michael F Green; Herbert Y Meltzer; James M Gold; Mary Sano
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.
Schizophrenia bulletin 2003;29(1):45-55.
2003: Herbert Y Meltzer; Larry Alphs; Alan I Green; A Carlo Altamura; Ravi Anand; Alberto Bertoldi; Marc Bourgeois; Guy Chouinard; M Zahur Islam; John M Kane; Ranga Krishnan; Jean-Pierre Lindenmayer; Steven G Potkin
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
Archives of general psychiatry 2003;60(1):82-91.
2003: Herbert Y Meltzer; Edward Perry; Karu Jayathilake
Clozapine-induced weight gain predicts improvement in psychopathology.
Schizophrenia research 2003;59(1):19-27.
2003: Tomiki Sumiyoshi; Karu Jayathilake; Herbert Y Meltzer
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Schizophrenia research 2003;59(1):7-16.
2002: Junji Ichikawa; Young-Chul Chung; Zhu Li; Jin Dai; Herbert Y Meltzer
Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Brain research 2002;958(1):176-84.
2002: Vincenzo S Basile; Mario Masellis; Vincenzo De Luca; Herbert Y Meltzer; James L Kennedy
759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.
Lancet 2002;360(9347):1790-1.
2002: Junji Ichikawa; Zhu Li; Jin Dai; Herbert Y Meltzer
Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Brain research 2002;956(2):349-57.
2002: Grazyna Rajkowska; Jose Javier Miguel-Hidalgo; Zoltan Makkos; Herbert Y Meltzer; James C Overholser; Craig A Stockmeier
Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia.
Schizophrenia research 2002;57(2-3):127-38.
2002: Stefania Bonaccorso; Herbert Y Meltzer; Zhu Li; Jin Dai; Anna R Alboszta; Junji Ichikawa
SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(3):430-41.
2002: M Arato; R O'Connor; Herbert Y Meltzer
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.
International clinical psychopharmacology 2002;17(5):207-15.
2002: Jean-François Liégeois; Junji Ichikawa; Herbert Y Meltzer
5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
Brain research 2002;947(2):157-65.
2002: Nicola Singleton; Herbert Y Meltzer
Mental disorders in prisoners.
Lancet 2002;360(9332):572-3; author reply 573.
2002: Herbert Y Meltzer
Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
Psychopharmacology 2002;163(1):1-3.
2002: Herbert Y Meltzer
Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options.
Current psychiatry reports 2002;4(4):279-83.
2002: Craig A Stockmeier; Xiaochun Shi; Lisa C Konick; James C Overholser; George J Jurjus; Herbert Y Meltzer; Lee Friedman; Pierre Blier; Grazyna Rajkowska
Neurokinin-1 receptors are decreased in major depressive disorder.
Neuroreport 2002;13(9):1223-7.
2002: Bernard Lerer; Ronnen Segman; Heiner Fangerau; Ann K Daly; Vincenzo S Basile; Roberto Cavallaro; Harald N Aschauer; Robin G McCreadie; Stephanie Ohlraun; Nicol Ferrier; Mario Masellis; Massimiliano Verga; Joachim Scharfetter; Marcella Rietschel; Roger Lovlie; Uriel Heresco Levy; Herbert Y Meltzer; James L Kennedy; Vidar M Steen; Fabio Macciardi
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(1):105-19.
2002: Junji Ichikawa; Jin Dai; Herbert Y Meltzer
5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Brain research 2002;939(1-2):34-42.
2002: Robert M Kessler; Herbert Y Meltzer
Regional selectivity in clozapine treatment?
The American journal of psychiatry 2002;159(6):1064-5.
2002: Junji Ichikawa; Jin Dai; Ian A O'Laughlin; Wiley L Fowler; Herbert Y Meltzer
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(3):325-39.
2002: Herbert Y Meltzer
Clozapine and suicide.
The American journal of psychiatry 2002;159(2):323-4.
2002: Stefania Bonaccorso; Valentina Marino; Antonella Puzella; Massimo Pasquini; Massimo Biondi; Marco Artini; Cristiana Almerighi; Robert Verkerk; Herbert Y Meltzer; Michael Maes
Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
Journal of clinical psychopharmacology 2002;22(1):86-90.
2002: Herbert Y Meltzer; Michael Davidson; Alexander H Glassman; W Victor R Vieweg
Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
The Journal of clinical psychiatry 2002;63 Suppl 9():25-9.
2002: Herbert Y Meltzer
Action of atypical antipsychotics.
The American journal of psychiatry 2002;159(1):153-4; author reply 154-5.
2001: Herbert Y Meltzer; Tomiki Sumiyoshi; Karu Jayathilake
Melperone in the treatment of neuroleptic-resistant schizophrenia.
Psychiatry research 2001;105(3):201-9.
2001: Stefania Bonaccorso; Antonella Puzella; Valentina Marino; Massimo Pasquini; Massimo Biondi; Marco Artini; Cristiana Almerighi; Massimo Levrero; B Egyed; Eugene Bosmans; Herbert Y Meltzer; Michael Maes
Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.
Psychiatry research 2001;105(1-2):45-55.
2001: M A Lee; Herbert Y Meltzer
5-HT(1A) receptor dysfunction in female patients with schizophrenia.
Biological psychiatry 2001;50(10):758-66.
2001: Tomiki Sumiyoshi; Mié Matsui; Shigeru Nohara; Ikiko Yamashita; Masayoshi Kurachi; Chika Sumiyoshi; Karu Jayathilake; Herbert Y Meltzer
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment.
The American journal of psychiatry 2001;158(10):1722-5.
2001: Laura Rauser; Jason E Savage; Herbert Y Meltzer; Bryan L Roth
Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
The Journal of pharmacology and experimental therapeutics 2001;299(1):83-9.
2001: Jung H Lee; Jong Inn Woo; Herbert Y Meltzer
Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia.
Psychiatry research 2001;103(2-3):157-66.
2001: Violetta Klimek; Meng-Yang Zhu; GE Dilley; Lisa C Konick; James C Overholser; Herbert Y Meltzer; Warren L May; Craig A Stockmeier; Gregory A Ordway
Effects of long-term cigarette smoking on the human locus coeruleus.
Archives of general psychiatry 2001;58(9):821-7.
2001: Junji Ichikawa; Jin Dai; Herbert Y Meltzer
DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
Brain research 2001;907(1-2):151-5.
2001: Michael Maes; Stefania Bonaccorso; Valentina Marino; Antonella Puzella; Massimo Pasquini; Massimo Biondi; Marco Artini; Cristiana Almerighi; Herbert Y Meltzer
Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
Molecular psychiatry 2001;6(4):475-80.
2001: Tomiki Sumiyoshi; Mié Matsui; Ikiko Yamashita; Shigeru Nohara; Masayoshi Kurachi; Takashi Uehara; S Sumiyoshi; Chika Sumiyoshi; Herbert Y Meltzer
The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia.
Biological psychiatry 2001;49(10):861-8.
2001: Colleen M Niswender; Katharine Herrick-Davis; GE Dilley; Herbert Y Meltzer; James C Overholser; Craig A Stockmeier; Ronald B Emeson; Elaine Sanders-Bush
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):478-91.
2001: Herbert Y Meltzer
Treatment of suicidality in schizophrenia.
Annals of the New York Academy of Sciences 2001;932():44-58; discussion 58-60.
2001: Vincenzo S Basile; Vural Ozdemir; Mario Masellis; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Fabio Macciardi; Arturas Petronis; James L Kennedy
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Molecular psychiatry 2001;6(2):230-4.
2001: Junji Ichikawa; H Ishii; S Bonaccorso; W L Fowler; I A O'Laughlin; Herbert Y Meltzer
5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Journal of neurochemistry 2001;76(5):1521-31.
2001: Herbert Y Meltzer; M A Lee; Karu Jayathilake
The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(3):278-90.
2001: Mario Masellis; Vincenzo S Basile; Herbert Y Meltzer; Jeffrey A Lieberman; Serge Sevy; David Goldman; M W Hamblin; Fabio Macciardi; James L Kennedy
Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.
Schizophrenia research 2001;47(1):49-58.
2001: Herbert Y Meltzer
Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
The Journal of clinical psychiatry 2001;62 Suppl 27():35-9; discussion 40-1.
2001: Vincenzo S Basile; Mario Masellis; Roger S McIntyre; Herbert Y Meltzer; J A Lieberman; James L Kennedy
Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
The Journal of clinical psychiatry 2001;62 Suppl 23():45-66.
2001: Richard C Shelton; Gary D Tollefson; Mauricio Tohen; S Stahl; K S Gannon; Thomas G Jacobs; W R Buras; Frank P Bymaster; W Zhang; K A Spencer; Peter Feldman; Herbert Y Meltzer
A novel augmentation strategy for treating resistant major depression.
The American journal of psychiatry 2001;158(1):131-4.
2000: Susan R McGurk; Herbert Y Meltzer
The role of cognition in vocational functioning in schizophrenia.
Schizophrenia research 2000;45(3):175-84.
2000: Jose Javier Miguel-Hidalgo; C Baucom; GE Dilley; James C Overholser; Herbert Y Meltzer; Craig A Stockmeier; Grazyna Rajkowska
Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder.
Biological psychiatry 2000;48(8):861-73.
2000: T Kuroki; Jin Dai; Herbert Y Meltzer; Junji Ichikawa
R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex.
Brain research 2000;872(1-2):204-7.
2000: Vincenzo S Basile; Vural Ozdemir; Mario Masellis; M L Walker; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Gustavo Alva; Werner Kalow; Fabio Macciardi; James L Kennedy
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
Molecular psychiatry 2000;5(4):410-7.
2000: Herbert Y Meltzer
Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?
Psychopharmacology 2000;150(3):349-50.
2000: T Sumiyoshi; Mié Matsui; I Yamashita; S Nohara; T Uehara; M Kurachi; Herbert Y Meltzer
Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.
Journal of clinical psychopharmacology 2000;20(3):386-8.
2000: Junji Ichikawa; Herbert Y Meltzer
The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Brain research 2000;858(2):252-63.
2000: John B Vincent; Maria Neves-Pereira; Andrew D Paterson; E Yamamoto; sagar parikh; Fabio Macciardi; Hugh M D Gurling; S G Potkin; Carlos N Pato; antonio macedo; M Kovacs; M Davies; J A Lieberman; Herbert Y Meltzer; Arturas Petronis; James L Kennedy
An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus.
American journal of human genetics 2000;66(3):819-29.
2000: Mario Masellis; Vincenzo S Basile; Vural Ozdemir; Herbert Y Meltzer; Fabio Macciardi; James L Kennedy
Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
Biological psychiatry 2000;47(3):252-66.
2000: Herbert Y Meltzer
Genetics and etiology of schizophrenia and bipolar disorder.
Biological psychiatry 2000;47(3):171-3.
2000: Sohee Park; C Knopick; S McGurk; Herbert Y Meltzer
Nicotine impairs spatial working memory while leaving spatial attention intact.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(2):200-9.
2000: Robert R Conley; Herbert Y Meltzer
Adverse events related to olanzapine.
The Journal of clinical psychiatry 2000;61 Suppl 8():26-9; discussion 30.
2000: Herbert Y Meltzer
An atypical compound by any other name is still a.
Psychopharmacology 2000;148(1):16-9.
1999: Junji Ichikawa; Herbert Y Meltzer
R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1227-32.
1999: Herbert Y Meltzer; S Park; R Kessler
Cognition, schizophrenia, and the atypical antipsychotic drugs.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):13591-3.
1999: Herbert Y Meltzer
Treatment of schizophrenia and spectrum disorders: pharmacotherapy, psychosocial treatments, and neurotransmitter interactions.
Biological psychiatry 1999;46(10):1321-7.
1999: Gregory A Ordway; J T Farley; GE Dilley; James C Overholser; Herbert Y Meltzer; Elizabeth Balraj; Craig A Stockmeier; Violetta Klimek
Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression.
Brain research 1999;847(1):71-9.
1999: Meng-Yang Zhu; Violetta Klimek; GE Dilley; J W Haycock; Craig A Stockmeier; James C Overholser; Herbert Y Meltzer; Gregory A Ordway
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression.
Biological psychiatry 1999;46(9):1275-86.
1999: Junji Ichikawa; Herbert Y Meltzer
The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens.
Brain research 1999;842(2):445-51.
1999: Junji Ichikawa; Herbert Y Meltzer
Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation.
European journal of pharmacology 1999;380(1):R1-3.
1999: Herbert Y Meltzer
The role of serotonin in antipsychotic drug action.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(2 Suppl):106S-115S.
1999: Herbert Y Meltzer
Risperidone and clozapine for treatment-resistant schizophrenia.
The American journal of psychiatry 1999;156(7):1126-7; author reply 1127-8.
1999: Herbert Y Meltzer
Dopamine2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptic?
Biological psychiatry 1999;46(1):144-9.
1999: Violetta Klimek; Grazyna Rajkowska; S N Luker; GE Dilley; Herbert Y Meltzer; James C Overholser; Craig A Stockmeier; Gregory A Ordway
Brain noradrenergic receptors in major depression and schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(1):69-81.
1999: Vincenzo S Basile; Mario Masellis; F Badri; A D Paterson; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Fabio Macciardi; James L Kennedy
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(1):17-27.
1999: CD Young; Michael Bubser; Herbert Y Meltzer; Ariel Deutch
Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation.
Psychopharmacology 1999;144(3):255-63.
1999: Marcella Rietschel; James L Kennedy; F Macciardi; Herbert Y Meltzer
Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies.
Schizophrenia research 1999;37(2):191-6.
1999: M A Lee; Karu Jayathilake; Herbert Y Meltzer
A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.
Schizophrenia research 1999;37(1):1-11.
1999: John B Vincent; Arturas Petronis; E Strong; sagar parikh; Herbert Y Meltzer; J Lieberman; James L Kennedy
Analysis of genome-wide CAG/CTG repeats, and at SEF2-1B and ERDA1 in schizophrenia and bipolar affective disorder.
Molecular psychiatry 1999;4(3):229-34.
1999: Grazyna Rajkowska; Jose Javier Miguel-Hidalgo; J Wei; GE Dilley; S D Pittman; Herbert Y Meltzer; James C Overholser; Bryan L Roth; Craig A Stockmeier
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.
Biological psychiatry 1999;45(9):1085-98.
1999: Michael Maes; I Libbrecht; F Van Hunsel; D Campens; Herbert Y Meltzer
Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
Journal of clinical psychopharmacology 1999;19(2):177-82.
1999: Michael Maes; Armand Christophe; Joris Delanghe; Carlo A Altamura; Hugo Neels; Herbert Y Meltzer
Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.
Psychiatry research 1999;85(3):275-91.
1999: P Truffinet; Carol A Tamminga; L F Fabre; Herbert Y Meltzer; M E Rivière; C Papillon-Downey
Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia.
The American journal of psychiatry 1999;156(3):419-25.
1999: Barnett S Meyers; George S Alexopoulos; Tatsu Kakuma; F Tirumalasetti; Michelle Gabriele; S Alpert; Charles L Bowden; Herbert Y Meltzer
Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression.
Biological psychiatry 1999;45(4):448-52.
1999: Michael Maes; A Van Gastel; L Delmeire; Herbert Y Meltzer
Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine.
Biological psychiatry 1999;45(3):278-84.
1999: T Kuroki; Herbert Y Meltzer; J Ichikawa
Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
The Journal of pharmacology and experimental therapeutics 1999;288(2):774-81.
1999: J Ichikawa; Herbert Y Meltzer
Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():90-8.
1999: Herbert Y Meltzer; S R McGurk
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
Schizophrenia bulletin 1999;25(2):233-55.
1999: Herbert Y Meltzer
Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial.
The Journal of clinical psychiatry 1999;60 Suppl 12():47-50.
1999: Herbert Y Meltzer; Karu Jayathilake
Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine?
The Journal of clinical psychiatry 1999;60 Suppl 10():47-51.
1999: Herbert Y Meltzer
Outcome in schizophrenia: beyond symptom reduction.
The Journal of clinical psychiatry 1999;60 Suppl 3():3-7; discussion 8.
1998: Mario Masellis; Vincenzo S Basile; Herbert Y Meltzer; Jeffrey A Lieberman; Serge Sevy; Fabio Macciardi; P Cola; A Howard; F Badri; M M Nöthen; Werner Kalow; James L Kennedy
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(2):123-32.
1998: S Hossein Fatemi; Robert Sidwell; David A Kist; P Akhter; Herbert Y Meltzer; K Bailey; Paul Thuras; J Sedgwick
Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero.
Brain research 1998;800(1):1-9.
1998: CD Young; Herbert Y Meltzer; Ariel Deutch
Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(1):99-103.
1998: W W Hong; I W Rak; V T Ciuryla; A M Wilson; J W Kylstra; Herbert Y Meltzer; William T Carpenter; Anthony Lehman; L A Arvanitis
Medical-claims databases in the design of a health-outcomes comparison of quetiapine ('Seroquel') and usual-care antipsychotic medication.
Schizophrenia research 1998;32(1):51-8.
1998: Junji Ichikawa; T Kuroki; Jin Dai; Herbert Y Meltzer
Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
European journal of pharmacology 1998;351(2):163-71.
1998: Junji Ichikawa; T Kuroki; Herbert Y Meltzer
Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens.
European journal of pharmacology 1998;350(2-3):159-64.
1998: W T Summerfelt; Herbert Y Meltzer
Efficacy vs. effectiveness in psychiatric research.
Psychiatric services (Washington, D.C.) 1998;49(6):834-5.
1998: Herbert Y Meltzer; Myung Lee; P Cola
The evolution of treatment resistance: biologic implications.
Journal of clinical psychopharmacology 1998;18(2 Suppl 1):5S-11S.
1998: Herbert Y Meltzer; D Pringuey
Treatment-resistant schizophrenia: the importance of early detection and treatment. Introduction.
Journal of clinical psychopharmacology 1998;18(2 Suppl 1):1S.
1998: Richard Scott Jope; Ling Song; CA Grimes; MA Pacheco; GE Dilley; Xinmin Li; Herbert Y Meltzer; James C Overholser; Craig A Stockmeier
Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence.
Journal of neurochemistry 1998;70(2):763-71.
1998: DL Willins; Herbert Y Meltzer
Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
Brain research 1998;781(1-2):291-9.
1998: Herbert Y Meltzer
Suicide in schizophrenia: risk factors and clozapine treatment.
The Journal of clinical psychiatry 1998;59 Suppl 3():15-20.
1998: Bryan L Roth; Herbert Y Meltzer; N Khan
Binding of typical and atypical antipsychotic drugs to multiple neurotransmitter receptors.
Advances in pharmacology (San Diego, Calif.) 1998;42():482-5.
1997: Violetta Klimek; Craig A Stockmeier; James C Overholser; Herbert Y Meltzer; S Kalka; GE Dilley; Gregory A Ordway
Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(21):8451-8.
1997: Michael Maes; H Westenberg; E Vandoolaeghe; P Demedts; Annick Wauters; Hugo Neels; Herbert Y Meltzer
Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
Journal of clinical psychopharmacology 1997;17(5):358-64.
1997: Michael Maes; E Vandoolaeghe; Hugo Neels; P Demedts; Annick Wauters; Herbert Y Meltzer; Carlo A Altamura; R Desnyder
Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.
Biological psychiatry 1997;42(5):349-58.
1997: Michael Maes; Eugene Bosmans; Gunter Kenis; R De Jong; R S Smith; Herbert Y Meltzer
In vivo immunomodulatory effects of clozapine in schizophrenia.
Schizophrenia research 1997;26(2-3):221-5.
1997: Herbert Y Meltzer
Clozapine withdrawal: serotonergic or dopaminergic mechanisms?
Archives of general psychiatry 1997;54(8):760-3.
1997: DL Willins; Herbert Y Meltzer
Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
The Journal of pharmacology and experimental therapeutics 1997;282(2):699-706.
1997: J T Abraham; R Brown; Herbert Y Meltzer
Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use.
Biological psychiatry 1997;42(2):144-6.
1997: M Maes; Joseph Calabrese; Karu Jayathilake; Herbert Y Meltzer
Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission.
Psychiatry research 1997;71(2):67-76.
1997: Herbert Y Meltzer; B Bastani; Karu Jayathilake; M Maes
Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(1):1-11.
1997: T Sumiyoshi; J Ichikawa; Herbert Y Meltzer
Increased S(-)-apomorphine-induced vacuous chewing and attenuated effect of chronic haloperidol treatment in streptozotocin-induced diabetic rat.
Pharmacology, biochemistry, and behavior 1997;57(1-2):19-22.
1997: M A Parsa; E Szigethy; J M Voci; Herbert Y Meltzer
Risperidone in treatment of choreoathetosis of Huntington's disease.
Journal of clinical psychopharmacology 1997;17(2):134-5.
1997: Y M Al-Semaan; H A Clay; Herbert Y Meltzer
Clozapine in treatment of bromocriptine-induced psychosis.
Journal of clinical psychopharmacology 1997;17(2):126-8.
1997: Herbert Y Meltzer; J Rabinowitz; M A Lee; P A Cola; R Ranjan; Robert L Findling; Paul Thompson
Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.
The American journal of psychiatry 1997;154(4):475-82.
1997: T Sumiyoshi; M Hasegawa; Karu Jayathilake; Herbert Y Meltzer
Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
Psychiatry research 1997;69(2-3):113-21.
1997: Peter F Buckley; Lee Friedman; D Wu; S Lai; Herbert Y Meltzer; E Mark Haacke; D Miller; JONATHAN LEWIN
Functional magnetic resonance imaging in schizophrenia: initial methodology and evaluation of the motor cortex.
Psychiatry research 1997;74(1):13-23.
1997: T Sumiyoshi; J Ichikawa; Herbert Y Meltzer
The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(3):183-90.
1997: Michael Maes; R Smith; Armand Christophe; E Vandoolaeghe; A Van Gastel; Hugo Neels; P Demedts; Annick Wauters; Herbert Y Meltzer
Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers.
Acta psychiatrica Scandinavica 1997;95(3):212-21.
1997: T Sumiyoshi; M Hasegawa; Karu Jayathilake; Herbert Y Meltzer
Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance.
Biological psychiatry 1997;41(5):560-6.
1997: Craig A Stockmeier; GE Dilley; L A Shapiro; James C Overholser; Paul Thompson; Herbert Y Meltzer
Serotonin receptors in suicide victims with major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(2):162-73.
1997: Michael Maes; J Delange; R Ranjan; Herbert Y Meltzer; R Desnyder; W Cooremans; Simon Scharpé
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs.
Psychiatry research 1997;66(1):1-11.
1997: Herbert Y Meltzer
Treatment-resistant schizophrenia--the role of clozapine.
Current medical research and opinion 1997;14(1):1-20.
1997: Traci A Stuve; Lee Friedman; John A Jesberger; Grover C Gilmore; Milton E Strauss; Herbert Y Meltzer
The relationship between smooth pursuit performance, motion perception and sustained visual attention in patients with schizophrenia and normal controls.
Psychological medicine 1997;27(1):143-52.
1996: T Kuroki; J Ichikawa; J Dai; Herbert Y Meltzer
R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.
Brain research 1996;743(1-2):357-61.
1996: Michael Maes; Herbert Y Meltzer
Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
Psychiatry research 1996;64(3):147-59.
1996: Herbert Y Meltzer; P A Cola; M Parsa
Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):395-405.
1996: Michael Maes; A Van Gastel; R Ranjan; P Blockx; Paul Cosyns; Herbert Y Meltzer; R Desnyder
Stimulatory effects of L-5-hydroxytryptophan on postdexamethasone beta-endorphin levels in major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):340-8.
1996: Robert L Findling; Karu Jayathilake; Herbert Y Meltzer
Pre-morbid asociality in neuroleptic-resistant and neuroleptic-responsive schizophrenia.
Psychological medicine 1996;26(5):1033-41.
1996: JONATHAN LEWIN; Lee Friedman; D Wu; D A Miller; Lee A Thompson; S K Klein; A L Wise; P Hedera; Peter F Buckley; Herbert Y Meltzer; Robert P Friedland; Jeffrey L Duerk
Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm.
Journal of computer assisted tomography 1996;20(5):695-701.
1996: C J Hudson; James L Kennedy; A Gotowiec; A Lin; N King; K Gojtan; Fabio Macciardi; K Skorecki; Herbert Y Meltzer; Jerry J Warsh; D F Horrobin
Genetic variant near cytosolic phospholipase A2 associated with schizophrenia.
Schizophrenia research 1996;21(2):111-6.
1996: R Ranjan; Herbert Y Meltzer
Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression.
Biological psychiatry 1996;40(4):253-8.
1996: H Elkis; Lee Friedman; Peter F Buckley; H S Lee; Christine Lys; B Kaufman; Herbert Y Meltzer
Increased prefrontal sulcal prominence in relatively young patients with unipolar major depression.
Psychiatry research 1996;67(2):123-34.
1996: T Sasaki; Fabio Macciardi; F Badri; Massimo Verga; Herbert Y Meltzer; J Lieberman; A Howard; graham bean; R T Joffe; C J Hudson; James L Kennedy
No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
American journal of medical genetics 1996;67(4):415-7.
1996: Michael Maes; Eugene Bosmans; R Ranjan; E Vandoolaeghe; Herbert Y Meltzer; M De Ley; R Berghmans; G Stans; R Desnyder
Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs.
Schizophrenia research 1996;21(1):39-50.
1996: P F Goyer; Marc S Berridge; Evan D Morris; WE Semple; B A Compton-Toth; S Charles Schulz; Dean F Wong; FD Miraldi; Herbert Y Meltzer
PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(7):1122-7.
1996: M A Pacheco; Craig A Stockmeier; Herbert Y Meltzer; James C Overholser; GE Dilley; Richard Scott Jope
Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain.
Brain research 1996;723(1-2):37-45.
1996: Joseph Calabrese; Susan E Kimmel; M J Woyshville; Daniel J Rapport; C J Faust; Paul Thompson; Herbert Y Meltzer
Clozapine for treatment-refractory mania.
The American journal of psychiatry 1996;153(6):759-64.
1996: John B Vincent; TA Klempan; sagar parikh; T Sasaki; Herbert Y Meltzer; Giorgio Sirugo; P Cola; Arturas Petronis; James L Kennedy
Frequency analysis of large CAG/CTG trinucleotide repeats in schizophrenia and bipolar affective disorder.
Molecular psychiatry 1996;1(2):141-8.
1996: Herbert Y Meltzer
Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review.
The British journal of psychiatry. Supplement 1996;(29):23-31.
1996: Michael Maes; R Smith; A Christophe; Paul Cosyns; R Desnyder; Herbert Y Meltzer
Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids.
Journal of affective disorders 1996;38(1):35-46.
1996: Herbert Y Meltzer; M A Lee; R Ranjan; E A Mason; P A Cola
Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
Psychopharmacology 1996;124(1-2):176-87.
1996: Herbert Y Meltzer; P A Thompson; M A Lee; R Ranjan
Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;14(3 Suppl):27S-33S.
1996: Martha Sajatovic; Herbert Y Meltzer
Clozapine-induced myoclonus and generalized seizures.
Biological psychiatry 1996;39(5):367-70.
1996: T Sumiyoshi; Craig A Stockmeier; James C Overholser; GE Dilley; Herbert Y Meltzer
Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.
Brain research 1996;708(1-2):209-14.
1996: Herbert Y Meltzer; H C Fibiger
Olanzapine: a new typical antipsychotic drug.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;14(2):83-5.
1996: T Sasaki; E Billett; Arturas Petronis; D Ying; T Parsons; Fabio Macciardi; Herbert Y Meltzer; J Lieberman; R T Joffe; Christopher A Ross; Melvin G McInnis; S H Li; James L Kennedy
Psychosis and genes with trinucleotide repeat polymorphism.
Human genetics 1996;97(2):244-6.
1996: Herbert Y Meltzer; Michael Maes
Effect of pindolol on hormone secretion and body temperature: partial agonist effects.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(1-2):77-88.
1996: Michael Maes; Ingrid De Meester; Simon Scharpe; R Desnyder; R Ranjan; Herbert Y Meltzer
Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
Acta psychiatrica Scandinavica 1996;93(1):1-8.
1996: Michael Maes; A Van Gastel; Herbert Y Meltzer; Paul Cosyns; P Blockx; R Desnyder
Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
Psychoneuroendocrinology 1996;21(1):67-81.
1996: Ruth Kohen; M A Metcalf; N Khan; T Druck; K Huebner; J E Lachowicz; Herbert Y Meltzer; David R Sibley; Bryan L Roth; Mark W Hamblin
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Journal of neurochemistry 1996;66(1):47-56.
1995: James L Kennedy; E A Billett; Fabio Macciardi; Massimo Verga; T J Parsons; Herbert Y Meltzer; J Lieberman; J A Buchanan
Association study of dopamine D3 receptor gene and schizophrenia.
American journal of medical genetics 1995;60(6):558-62.
1995: J Ichikawa; T Kuroki; M T Kitchen; Herbert Y Meltzer
R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens.
European journal of pharmacology 1995;287(2):179-84.
1995: J Ichikawa; Herbert Y Meltzer
DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum.
Brain research 1995;698(1-2):204-8.
1995: Mario Masellis; Andrew D Paterson; F Badri; Jeffrey A Lieberman; Herbert Y Meltzer; P Cavazzoni; James L Kennedy
Genetic variation of 5-HT2A receptor and response to clozapine.
Lancet 1995;346(8982):1108.
1995: Michael Maes; F Goossens; Simon Scharpé; Joseph Calabrese; R Desnyder; Herbert Y Meltzer
Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs.
Psychiatry research 1995;58(3):217-25.
1995: Arturas Petronis; Fabio Macciardi; A Athanassiades; Andrew D Paterson; Massimo Verga; Herbert Y Meltzer; P Cola; J A Buchanan; Hubert H M Van Tol; James L Kennedy
Association study between the dopamine D4 receptor gene and schizophrenia.
American journal of medical genetics 1995;60(5):452-5.
1995: Herbert Y Meltzer; Michael Maes
Effects of ipsapirone on plasma cortisol and body temperature in major depression.
Biological psychiatry 1995;38(7):450-7.
1995: Gregory A Ordway; Craig A Stockmeier; Herbert Y Meltzer; James C Overholser; S Jaconetta; P S Widdowson
Neuropeptide Y in frontal cortex is not altered in major depression.
Journal of neurochemistry 1995;65(4):1646-50.
1995: Herbert Y Meltzer; Michael Maes
Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
Psychiatry research 1995;58(2):89-98.
1995: H Elkis; L Friedman; A Wise; Herbert Y Meltzer
Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia.
Archives of general psychiatry 1995;52(9):735-46.
1995: Herbert Y Meltzer; Michael Maes
Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.
Biological psychiatry 1995;38(5):310-8.
1995: Michael Maes; Herbert Y Meltzer; Eugene Bosmans; R Bergmans; E Vandoolaeghe; R Ranjan; R Desnyder
Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
Journal of affective disorders 1995;34(4):301-9.
1995: J Ichikawa; Herbert Y Meltzer
Effect of antidepressants on striatal and accumbens extracellular dopamine levels.
European journal of pharmacology 1995;281(3):255-61.
1995: Bryan L Roth; S Tandra; L H Burgess; David R Sibley; Herbert Y Meltzer
D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.
Psychopharmacology 1995;120(3):365-8.
1995: DW Hudgel; E A Gordon; Herbert Y Meltzer
Abnormal serotonergic stimulation of cortisol production in obstructive sleep apnea.
American journal of respiratory and critical care medicine 1995;152(1):186-92.
1995: Herbert Y Meltzer
Clozapine: is another view valid?
The American journal of psychiatry 1995;152(6):821-5.
1995: T Sumiyoshi; Craig A Stockmeier; James C Overholser; Paul Thompson; Herbert Y Meltzer
Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
Brain research 1995;681(1-2):109-16.
1995: Herbert Y Meltzer
Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
Archives of general psychiatry 1995;52(3):200-2.
1995: Lee Friedman; John A Jesberger; L J Siever; P Thompson; Richard C Mohs; Herbert Y Meltzer
Smooth pursuit performance in patients with affective disorders or schizophrenia and normal controls: analysis with specific oculomotor measures, RMS error and qualitative ratings.
Psychological medicine 1995;25(2):387-403.
1995: Michael Maes; Eugene Bosmans; Joseph Calabrese; R Smith; Herbert Y Meltzer
Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
Journal of psychiatric research 1995;29(2):141-52.
1995: Lee Friedman; JT Kenny; John A Jesberger; M M Choy; Herbert Y Meltzer
Relationship between smooth pursuit eye-tracking and cognitive performance in schizophrenia.
Biological psychiatry 1995;37(4):265-72.
1995: Herbert Y Meltzer; G Okayli
Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.
The American journal of psychiatry 1995;152(2):183-90.
1995: Herbert Y Meltzer; James L Kennedy; J Dai; M Parsa; D Riley
Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;12(1):39-45.
1995: Herbert Y Meltzer
The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics.
Journal of clinical psychopharmacology 1995;15(1 Suppl 1):2S-3S.
1995: Carlo A Altamura; Michael Maes; J Dai; Herbert Y Meltzer
Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():71-5.
1995: Michael Maes; Herbert Y Meltzer; P D'Hondt; Paul Cosyns; P Blockx
Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression.
Psychoneuroendocrinology 1995;20(2):149-67.
1995: Michael Maes; Herbert Y Meltzer; Peter F Buckley; Eugene Bosmans
Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
European archives of psychiatry and clinical neuroscience 1995;244(6):325-9.
1995: M Maes; Eugene Bosmans; Herbert Y Meltzer
Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.
European archives of psychiatry and clinical neuroscience 1995;245(3):172-8.
1995: Herbert Y Meltzer
Role of serotonin in the action of atypical antipsychotic drugs.
Clinical neuroscience (New York, N.Y.) 1995;3(2):64-75.
1994: Herbert Y Meltzer
Serotonin2A receptors in schizophrenia: relation to suicide.
Archives of general psychiatry 1994;51(12):1003-4.
1994: Michael Maes; Herbert Y Meltzer; Paul Cosyns; Joseph Calabrese; P D'Hondt; P Blockx
Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(8):1273-92.
1994: M Maes; S Scharpé; Herbert Y Meltzer; G Okayli; Eugene Bosmans; P D'Hondt; B V Vanden Bossche; Paul Cosyns
Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response.
Psychiatry research 1994;54(2):143-60.
1994: Michael Maes; J Delanghe; Herbert Y Meltzer; Simon Scharpé; P D'Hondt; Paul Cosyns
Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research.
Acta psychiatrica Scandinavica 1994;90(4):252-8.
1994: Paul Thompson; Peter F Buckley; Herbert Y Meltzer
The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Journal of clinical psychopharmacology 1994;14(5):344-6.
1994: P B Vrtunski; L D Alphs; Herbert Y Meltzer
Motor mechanisms in schizophrenic patients with tardive dyskinesia.
Psychiatry research 1994;54(1):71-86.
1994: Susan E Kimmel; Joseph Calabrese; M J Woyshville; Herbert Y Meltzer
Clozapine in treatment-refractory mood disorders.
The Journal of clinical psychiatry 1994;55 Suppl B():91-3.
1994: M A Lee; Paul Thompson; Herbert Y Meltzer
Effects of clozapine on cognitive function in schizophrenia.
The Journal of clinical psychiatry 1994;55 Suppl B():82-7.
1994: Bryan K Yamamoto; Elizabeth A Pehek; Herbert Y Meltzer
Brain region effects of clozapine on amino acid and monoamine transmission.
The Journal of clinical psychiatry 1994;55 Suppl B():8-14.
1994: Herbert Y Meltzer
An overview of the mechanism of action of clozapine.
The Journal of clinical psychiatry 1994;55 Suppl B():47-52.
1994: Herbert Y Meltzer; P A Cola
The pharmacoeconomics of clozapine: a review.
The Journal of clinical psychiatry 1994;55 Suppl B():161-5.
1994: Peter F Buckley; Paul Thompson; L Way; Herbert Y Meltzer
Substance abuse and clozapine treatment.
The Journal of clinical psychiatry 1994;55 Suppl B():114-6.
1994: Peter F Buckley; Martha Sajatovic; Herbert Y Meltzer
Treatment of delusional disorders with clozapine.
The American journal of psychiatry 1994;151(9):1394-5.
1994: Herbert Y Meltzer; R Ranjan
Valproic acid treatment of clozapine-induced myoclonus.
The American journal of psychiatry 1994;151(8):1246-7.
1994: Lee Friedman; John A Jesberger; Herbert Y Meltzer
The effect of apomorphine, MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine) and placebo on smooth pursuit gain and corrective saccades in normal subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(1):49-62.
1994: M Hasegawa; P A Cola; Herbert Y Meltzer
Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(1):45-7.
1994: Michael Maes; Herbert Y Meltzer; Wim Stevens; Joseph Calabrese; Paul Cosyns
Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(4):717-30.
1994: P A Thompson; Michael Maes; Herbert Y Meltzer
Effect of the placebo control condition in neuroendocrine challenge studies.
Psychiatry research 1994;52(3):317-26.
1994: M A Lee; Herbert Y Meltzer
Blunted oral body temperature response to MK-212 in cocaine addicts.
Drug and alcohol dependence 1994;35(3):217-22.
1994: Michael Maes; Joseph Calabrese; Herbert Y Meltzer
The relevance of the in- versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(3):503-17.
1994: Michael Maes; Herbert Y Meltzer; Eugene Bosmans
Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
Acta psychiatrica Scandinavica 1994;89(5):346-51.
1994: Herbert Y Meltzer; Michael Maes
Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.
Psychopharmacology 1994;114(4):635-43.
1994: Michael Maes; F Goossens; Simon Scharpé; Herbert Y Meltzer; P D'Hondt; Paul Cosyns
Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression.
Biological psychiatry 1994;35(8):545-52.
1994: R C Arora; Herbert Y Meltzer
Effect of clozapine treatment on serotonin-2-receptor binding in the blood platelets of schizophrenic patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;10(2):109-14.
1994: Herbert Y Meltzer; B L Chai; Paul Thompson; Bryan K Yamamoto
Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1452-61.
1994: Peter F Buckley; P Thompson; L Way; Herbert Y Meltzer
Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.
The American journal of psychiatry 1994;151(3):385-9.
1994: E Mark Haacke; A Hopkins; S Lai; Peter F Buckley; L Friedman; Herbert Y Meltzer; P Hedera; Robert P Friedland; S Klein; L Thompson
2D and 3D high resolution gradient echo functional imaging of the brain: venous contributions to signal in motor cortex studies.
NMR in biomedicine 1994;7(1-2):54-62.
1994: Stanton L Gerson; C Arce; Herbert Y Meltzer
N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis.
British journal of haematology 1994;86(3):555-61.
1994: Herbert Y Meltzer; Michael Maes
Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects.
Biological psychiatry 1994;35(5):316-23.
1994: Michael Maes; Simon Scharpé; Paul Cosyns; Herbert Y Meltzer
Relationships between basal hypothalamic-pituitary-thyroid-axis activity and plasma haptoglobin levels in depression.
Journal of psychiatric research 1994;28(2):123-34.
1994: Bryan L Roth; S C Craigo; M S Choudhary; A Uluer; F J Monsma; Y Shen; Herbert Y Meltzer; David R Sibley
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1403-10.
1994: Michael Maes; Herbert Y Meltzer; Wim Stevens; Paul Cosyns; P Blockx
Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression.
Psychological medicine 1994;24(1):167-77.
1994: Michael Maes; Joseph Calabrese; M Lee; Herbert Y Meltzer
Effects of age on spontaneous cortisolaemia of normal volunteers and depressed patients.
Psychoneuroendocrinology 1994;19(1):79-84.
1994: Michael Maes; J Delanghe; Simon Scharpé; Herbert Y Meltzer; Paul Cosyns; E Suy; Eugene Bosmans
Haptoglobin phenotypes and gene frequencies in unipolar major depression.
The American journal of psychiatry 1994;151(1):112-6.
1994: Martha Sajatovic; LF Ramirez; JT Kenny; Herbert Y Meltzer
The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients.
Comprehensive psychiatry 1994;35(1):29-33.
1994: Michael Maes; Herbert Y Meltzer; P Blockx; Paul Cosyns; Joseph Calabrese
Ultrasensitive assay for measuring the intact (1-39) ACTH molecule: an asset in depression research.
Neuropsychobiology 1994;29(4):168-73.
1994: Michael Maes; Herbert Y Meltzer; Paul Cosyns; chris schotte
Evidence for the existence of major depression with and without anxiety features.
Psychopathology 1994;27(1-2):1-13.
1994: Michael Maes; Herbert Y Meltzer; E Bosmans
Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
Neuropsychobiology 1994;30(2-3):57-60.
1994: Herbert Y Meltzer; M A Lee; R Ranjan
Recent advances in the pharmacotherapy of schizophrenia.
Acta psychiatrica Scandinavica. Supplementum 1994;384():95-101.
1993: M Hasegawa; R Gutierrez-Esteinou; L Way; Herbert Y Meltzer
Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Journal of clinical psychopharmacology 1993;13(6):383-90.
1993: C Hagger; Peter F Buckley; JT Kenny; Lee Friedman; David Joseph Ubogy; Herbert Y Meltzer
Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.
Biological psychiatry 1993;34(10):702-12.
1993: Michael Maes; Simon Scharpé; Herbert Y Meltzer; Paul Cosyns
Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression.
Biological psychiatry 1993;34(10):690-701.
1993: Herbert Y Meltzer; P Cola; L Way; Paul Thompson; B Bastani; M A Davies; B Snitz
Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
The American journal of psychiatry 1993;150(11):1630-8.
1993: M Maes; Herbert Y Meltzer; S Scharpé; E Bosmans; E Suy; Ingrid De Meester; Joseph Calabrese; Paul Cosyns
Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression.
Psychiatry research 1993;49(2):151-65.
1993: P B Vrtunski; K L Lewis; Herbert Y Meltzer
Visual feedback in force control of schizophrenics.
Biological psychiatry 1993;34(9):667-70.
1993: M Maes; S Scharpé; Herbert Y Meltzer; E Bosmans; E Suy; Joseph Calabrese; Paul Cosyns
Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression.
Psychiatry research 1993;49(1):11-27.
1993: Shenghan Lai; A L Hopkins; E Mark Haacke; D Li; Bruce A Wasserman; Peter F Buckley; Lee Friedman; Herbert Y Meltzer; P Hedera; Robert P Friedland
Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at 1.5T: preliminary results.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1993;30(3):387-92.
1993: Paul Thompson; Herbert Y Meltzer
Positive, negative, and disorganisation factors from the Schedule for Affective Disorders and Schizophrenia and the Present State Examination. A three-factor solution.
The British journal of psychiatry : the journal of mental science 1993;163():344-51.
1993: Michael Maes; Paul Cosyns; Herbert Y Meltzer; F De Meyer; D Peeters
Seasonality in violent suicide but not in nonviolent suicide or homicide.
The American journal of psychiatry 1993;150(9):1380-5.
1993: Michael Maes; Herbert Y Meltzer; E Suy; F De Meyer
Seasonality in severity of depression: relationships to suicide and homicide occurrence.
Acta psychiatrica Scandinavica 1993;88(3):156-61.
1993: Craig A Stockmeier; J J DiCarlo; Y Zhang; P Thompson; Herbert Y Meltzer
Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1374-84.
1993: Elizabeth A Pehek; Herbert Y Meltzer; Bryan K Yamamoto
The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.
European journal of pharmacology 1993;240(1):107-9.
1993: george jaskiw; G Hussain; Herbert Y Meltzer
Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine.
Biological psychiatry 1993;34(3):188-90.
1993: Michael Maes; E Bosmans; Herbert Y Meltzer; Simon Scharpé; E Suy
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
The American journal of psychiatry 1993;150(8):1189-93.
1993: M Maes; R Dierckx; Herbert Y Meltzer; M Ingels; chris schotte; M Vandewoude; Joseph Calabrese; Paul Cosyns
Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings.
Psychiatry research 1993;50(2):77-88.
1993: Michael Maes; Herbert Y Meltzer; Simon Scharpé; W Cooreman; W Uyttenbroeck; E Suy; C Vandervorst; Joseph Calabrese; Jef Raus; Paul Cosyns
Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression.
Psychiatry research 1993;47(3):229-41.
1993: Herbert Y Meltzer
New drugs for the treatment of schizophrenia.
The Psychiatric clinics of North America 1993;16(2):365-85.
1993: R C Arora; Herbert Y Meltzer
Serotonin2 receptor binding in blood platelets of schizophrenic patients.
Psychiatry research 1993;47(2):111-9.
1993: Michael Maes; F De Meyer; D Peeters; Herbert Y Meltzer; chris schotte; Simon Scharpe; Paul Cosyns
The periodicities in and biometeorological relationships with bed occupancy of an acute psychiatric ward in Antwerp, Belgium.
International journal of biometeorology 1993;37(2):78-82.
1993: Michael Maes; Herbert Y Meltzer; Paul Cosyns; Joseph Calabrese; P D'Hondt; P Blockx; C Vandervorst; Jef Raus
Pituitary and adrenal hormone responsiveness to Synacthen in melancholic subjects versus subjects with minor depression.
Biological psychiatry 1993;33(8-9):624-9.
1993: M A Parsa; Y H al-Lahham; L F Ramirez; Herbert Y Meltzer
Prolonged psychotic relapse after abrupt clozapine withdrawal.
Journal of clinical psychopharmacology 1993;13(2):154-5.
1993: Peter F Buckley; Herbert Y Meltzer
Clozapine and NMS.
The British journal of psychiatry : the journal of mental science 1993;162():566.
1993: Michael Maes; Herbert Y Meltzer; E Suy; B Minner; Joseph Calabrese; Paul Cosyns
Sleep disorders and anxiety as symptom profiles of sympathoadrenal system hyperactivity in major depression.
Journal of affective disorders 1993;27(3):197-207.
1993: Michael Maes; Herbert Y Meltzer; J Jacobs; E Suy; Joseph Calabrese; B Minner; Jef Raus
Autoimmunity in depression: increased antiphospholipid autoantibodies.
Acta psychiatrica Scandinavica 1993;87(3):160-6.
1993: M A Parsa; M Simon; C Dubrow; L F Ramirez; Herbert Y Meltzer
Psychiatric manifestations of olivo-ponto-cerebellar atrophy and treatment with clozapine.
International journal of psychiatry in medicine 1993;23(2):149-56.
1993: Michael Maes; Herbert Y Meltzer; Paul Cosyns; E Suy; chris schotte
An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study.
Psychoneuroendocrinology 1993;18(8):607-20.
1993: Herbert Y Meltzer
Serotonin receptors and antipsychotic drug action.
Psychopharmacology series 1993;10():70-81.
1993: Herbert Y Meltzer; Michael Maes; M A Lee
The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.
Psychopharmacology 1993;112(1 Suppl):S95-104.
1992: Ian Brockington; A Roper; E Edmunds; C Kaufman; Herbert Y Meltzer
A longitudinal psychopathological schedule.
Psychological medicine 1992;22(4):1035-43.
1992: Michael Maes; F De Meyer; D Peeters; Herbert Y Meltzer; Paul Cosyns; chris schotte
Seasonal variation and meteotropism in various self-rated psychological and physiological features of a normal couple.
International journal of biometeorology 1992;36(4):195-200.
1992: Bryan K Yamamoto; Herbert Y Meltzer
The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
The Journal of pharmacology and experimental therapeutics 1992;263(1):180-5.
1992: Michael Maes; Simon Scharpé; Herbert Y Meltzer; E Suy; Paul Cosyns; Joseph Calabrese
Lower angiotensin I converting enzyme activity in melancholic subjects: a pilot study.
Biological psychiatry 1992;32(7):621-4.
1992: T Ohmori; R C Arora; Herbert Y Meltzer
Serotonergic measures in suicide brain: the concentration of 5-HIAA, HVA, and tryptophan in frontal cortex of suicide victims.
Biological psychiatry 1992;32(1):57-71.
1992: Herbert Y Meltzer; C A Stockmeier
In vivo occupancy of dopamine receptors by antipsychotic drugs.
Archives of general psychiatry 1992;49(7):588-9.
1992: Michael Maes; Wim Stevens; L DeClerck; D Peeters; Chris H Bridts; chris schotte; Herbert Y Meltzer; Simon Scharpé; Paul Cosyns
Neutrophil chemotaxis, phagocytosis, and superoxide release in depressive illness.
Biological psychiatry 1992;31(12):1220-4.
1992: B Chai; Herbert Y Meltzer
The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
Neuroscience letters 1992;140(1):47-50.
1992: Lee Friedman; Larry A Abel; John A Jesberger; A Malki; Herbert Y Meltzer
Saccadic intrusions into smooth pursuit in patients with schizophrenia or affective disorder and normal controls.
Biological psychiatry 1992;31(11):1110-8.
1992: J Ichikawa; Herbert Y Meltzer
Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
Journal of neurochemistry 1992;58(6):2285-91.
1992: Herbert Y Meltzer; Y Zhang; Craig A Stockmeier
Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
European journal of pharmacology 1992;216(1):67-71.
1992: D Nerozzi; A Magnani; C Dastoli; E Ferri; G Capesciotti; Italo Antonozzi; Gaetano Frajese; Herbert Y Meltzer
Prolactin responses to domperidone in chronic schizophrenia.
Psychiatry research 1992;42(2):159-69.
1992: Herbert Y Meltzer
Dimensions of outcome with clozapine.
The British journal of psychiatry. Supplement 1992;(17):46-53.
1992: Herbert Y Meltzer
The importance of serotonin-dopamine interactions in the action of clozapine.
The British journal of psychiatry. Supplement 1992;(17):22-9.
1992: J Ichikawa; Herbert Y Meltzer
The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
Brain research 1992;574(1-2):98-104.
1992: H S Lee; B Bastani; Lee Friedman; L Ramirez; Herbert Y Meltzer
Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia.
Biological psychiatry 1992;31(5):460-70.
1992: Bryan L Roth; R D Ciaranello; Herbert Y Meltzer
Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1361-5.
1992: Paul J Ambrosini; C Metz; R C Arora; J C Lee; L Kregel; Herbert Y Meltzer
Platelet imipramine binding in depressed children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry 1992;31(2):298-305.
1992: Herbert Y Meltzer; Gary A Gudelsky
Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.
Arzneimittel-Forschung 1992;42(2A):268-72.
1992: Herbert Y Meltzer; H S Lee; J F Nash
Effect of buspirone on prolactin secretion is not mediated by 5-HT-1a receptor stimulation.
Archives of general psychiatry 1992;49(2):163-4.
1992: Lee Friedman; John A Jesberger; Larry A Abel; Herbert Y Meltzer
Catch-up saccade amplitude is related to square wave jerk rate.
Investigative ophthalmology & visual science 1992;33(1):228-33.
1992: M Mikuni; Ariyuki Kagaya; K Takahashi; Herbert Y Meltzer
Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders.
Psychopharmacology 1992;106(3):311-4.
1992: Stanton L Gerson; Herbert Y Meltzer
Mechanisms of clozapine-induced agranulocytosis.
Drug safety : an international journal of medical toxicology and drug experience 1992;7 Suppl 1():17-25.
1992: C Attkisson; Judith A Cook; M Karno; Anthony Lehman; T H McGlashan; Herbert Y Meltzer; M O'Connor; D Richardson; A Rosenblatt; K Wells
Clinical services research.
Schizophrenia bulletin 1992;18(4):561-626.
1992: Herbert Y Meltzer
Treatment of the neuroleptic-nonresponsive schizophrenic patient.
Schizophrenia bulletin 1992;18(3):515-42.
1992: Lee Friedman; John A Jesberger; Herbert Y Meltzer
Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia.
Psychiatry research 1992;41(1):25-36.
1991: Joseph Calabrese; Herbert Y Meltzer; P J Markovitz
Clozapine prophylaxis in rapid cycling bipolar disorder.
Journal of clinical psychopharmacology 1991;11(6):396-7.
1991: Herbert Y Meltzer; J F Nash
Effects of antipsychotic drugs on serotonin receptors.
Pharmacological reviews 1991;43(4):587-604.
1991: M A Lee; Herbert Y Meltzer
Neuroendocrine responses to serotonergic agents in alcoholics.
Biological psychiatry 1991;30(10):1017-30.
1991: M A Parsa; L F Ramirez; E C Loula; Herbert Y Meltzer
Effect of clozapine on psychotic depression and parkinsonism.
Journal of clinical psychopharmacology 1991;11(5):330-1.
1991: Lee Friedman; John A Jesberger; Herbert Y Meltzer
A model of smooth pursuit performance illustrates the relationship between gain, catch-up saccade rate, and catch-up saccade amplitude in normal controls and patients with schizophrenia.
Biological psychiatry 1991;30(6):537-56.
1991: R C Arora; O B Emery; Herbert Y Meltzer
Serotonin uptake in the blood platelets of Alzheimer's disease patients.
Neurology 1991;41(8):1307-9.
1991: P J Markovitz; Joseph Calabrese; S C Schulz; Herbert Y Meltzer
Fluoxetine in the treatment of borderline and schizotypal personality disorders.
The American journal of psychiatry 1991;148(8):1064-7.
1991: S L Gerson; J A Lieberman; W R Friedenberg; D Lee; J J Marx; Herbert Y Meltzer
Polypharmacy in fatal clozapine-associated agranulocytosis.
Lancet 1991;338(8761):262-3.
1991: B Bastani; R C Arora; Herbert Y Meltzer
Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
Biological psychiatry 1991;30(2):131-9.
1991: H S Lee; K Y Kwon; L D Alphs; Herbert Y Meltzer
Effect of clozapine on psychogenic polydipsia in chronic schizophrenia.
Journal of clinical psychopharmacology 1991;11(3):222-3.
1991: Larry A Abel; Lee Friedman; John A Jesberger; A Malki; Herbert Y Meltzer
Quantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective disorders.
Biological psychiatry 1991;29(11):1063-72.
1991: R C Arora; Herbert Y Meltzer
Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims.
Biological psychiatry 1991;29(10):1016-22.
1991: Lee Friedman; L Knutson; M Shurell; Herbert Y Meltzer
Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia.
Biological psychiatry 1991;29(9):865-77.
1991: Herbert Y Meltzer
Beyond serotonin.
The Journal of clinical psychiatry 1991;52 Suppl():58-62.
1991: P B Vrtunski; L D Alphs; Herbert Y Meltzer
Isometric force control in schizophrenic patients with tardive dyskinesia.
Psychiatry research 1991;37(1):57-72.
1991: L D Alphs; Herbert Y Meltzer; B Bastani; LF Ramirez
Side effects of clozapine and their management.
Pharmacopsychiatry 1991;24(2):46.
1991: Herbert Y Meltzer; L D Alphs; B Bastani; LF Ramirez; K Kwon
Clinical efficacy of clozapine in the treatment of schizophrenia.
Pharmacopsychiatry 1991;24(2):44-5.
1991: Craig A Stockmeier; Herbert Y Meltzer
Beta-adrenergic receptor binding in frontal cortex of suicide victims.
Biological psychiatry 1991;29(2):183-91.
1991: M A Lee; J F Nash; M Barnes; Herbert Y Meltzer
Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.
Psychopharmacology 1991;103(2):258-64.
1991: S Matsubara; R C Arora; Herbert Y Meltzer
Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims.
Journal of neural transmission. General section 1991;85(3):181-94.
1991: JT Kenny; Herbert Y Meltzer
Attention and higher cortical functions in schizophrenia.
The Journal of neuropsychiatry and clinical neurosciences 1991;3(3):269-75.
1991: H S Lee; Herbert Y Meltzer
Buspirone does not produce a 5-HT1A-mediated decrease in temperature in man.
Journal of neural transmission. General section 1991;86(1):71-6.
1991: J Ichikawa; Herbert Y Meltzer
Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
The Journal of pharmacology and experimental therapeutics 1991;256(1):348-57.
1991: J F Nash; R C Arora; Martin A Schreiber; Herbert Y Meltzer
Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Biochemical pharmacology 1991;41(1):79-84.
1991: Herbert Y Meltzer
The mechanism of action of novel antipsychotic drugs.
Schizophrenia bulletin 1991;17(2):263-87.
1991: R C Arora; Herbert Y Meltzer
Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.
Journal of neural transmission. General section 1991;85(1):19-29.
1991: Martha Sajatovic; P Verbanac; LF Ramirez; Herbert Y Meltzer
Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea.
Neurology 1991;41(1):156.
1990: M A Parsa; T Rohr; L F Ramirez; Herbert Y Meltzer
Neuroleptic malignant syndrome without neuroleptics.
Journal of clinical psychopharmacology 1990;10(6):437-8.
1990: Herbert Y Meltzer
Monitoring clozapine.
Hospital & community psychiatry 1990;41(12):1356-7.
1990: D Nerozzi; A Magnani; V Sforza; E Scaramucci; Marco Cerilli; Costanzo Moretti; Gaetano Frajese; Italo Antonozzi; Herbert Y Meltzer
Plasma prolactin response to domperidone in acute schizophrenia and schizophreniform illness.
Psychiatry research 1990;34(2):139-47.
1990: B Bastani; J F Nash; Herbert Y Meltzer
Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
Archives of general psychiatry 1990;47(9):833-9.
1990: Herbert Y Meltzer; S Burnett; B Bastani; LF Ramirez
Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.
Hospital & community psychiatry 1990;41(8):892-7.
1990: M A Lee; M M Bowers; J F Nash; Herbert Y Meltzer
Neuroendocrine measures of dopaminergic function in chronic cocaine users.
Psychiatry research 1990;33(2):151-9.
1990: Martin Harrow; Joseph F Goldberg; Linda S Grossman; Herbert Y Meltzer
Outcome in manic disorders. A naturalistic follow-up study.
Archives of general psychiatry 1990;47(7):665-71.
1990: R C Arora; Herbert Y Meltzer
3H-imipramine binding in the blood platelets of normal twins.
Psychiatry research 1990;32(3):265-73.
1990: M T Lowy; J F Nash; Herbert Y Meltzer
Reserpine-induced DST nonsuppression in rats.
Biological psychiatry 1990;27(5):546-8.
1990: J F Nash; Herbert Y Meltzer; Gary A Gudelsky
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens.
Journal of neurochemistry 1990;54(3):1062-7.
1990: J Ichikawa; Herbert Y Meltzer
The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
European journal of pharmacology 1990;176(3):371-4.
1990: J Ichikawa; Herbert Y Meltzer
Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
Brain research 1990;507(1):138-42.
1990: Herbert Y Meltzer
Role of serotonin in depression.
Annals of the New York Academy of Sciences 1990;600():486-99; discussion 499-500.
1990: Herbert Y Meltzer
Defining treatment refractoriness in schizophrenia.
Schizophrenia bulletin 1990;16(4):563-5.
1990: Herbert Y Meltzer
Presynaptic receptors. Relevance to psychotropic drug action in man.
Annals of the New York Academy of Sciences 1990;604():353-71.
1989: D Helmuth; Z Ljaljevic; L Ramirez; Herbert Y Meltzer
Choreoathetosis induced by verapamil and lithium treatment.
Journal of clinical psychopharmacology 1989;9(6):454-5.
1989: R C Arora; Herbert Y Meltzer
3H-imipramine binding in the frontal cortex of suicides.
Psychiatry research 1989;30(2):125-35.
1989: Herbert Y Meltzer; S Matsubara; J C Lee
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
The Journal of pharmacology and experimental therapeutics 1989;251(1):238-46.
1989: J F Nash; Herbert Y Meltzer; Gary A Gudelsky
Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses.
Pharmacology, biochemistry, and behavior 1989;33(4):781-5.
1989: Herbert Y Meltzer
Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
Archives of general psychiatry 1989;46(7):672.
1989: R C Arora; Herbert Y Meltzer
Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects.
The American journal of psychiatry 1989;146(6):730-6.
1989: Gary A Gudelsky; S A Berry; Herbert Y Meltzer
Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat.
Neuroendocrinology 1989;49(6):604-9.
1989: M T Lowy; J F Nash; Herbert Y Meltzer
Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
European journal of pharmacology 1989;163(1):157-61.
1989: J F Nash; Herbert Y Meltzer
Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat.
The Journal of pharmacology and experimental therapeutics 1989;249(1):236-41.
1989: P B Vrtunski; D M Simpson; Herbert Y Meltzer
Voluntary movement dysfunction in schizophrenics.
Biological psychiatry 1989;25(5):529-39.
1989: Gary A Gudelsky; Herbert Y Meltzer
Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(1):45-51.
1989: R C Arora; Herbert Y Meltzer
Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
Life sciences 1989;44(11):725-34.
1989: Herbert Y Meltzer; B Bastani; K Y Kwon; LF Ramirez; S Burnett; J Sharpe
A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.
Psychopharmacology 1989;99 Suppl():S68-72.
1989: B Bastani; L D Alphs; Herbert Y Meltzer
Development of the Clozaril Patient Management System.
Psychopharmacology 1989;99 Suppl():S122-5.
1989: Herbert Y Meltzer
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.
Psychopharmacology 1989;99 Suppl():S18-27.
1989: Gary A Gudelsky; J F Nash; SA Berry; Herbert Y Meltzer
Basic biology of clozapine: electrophysiological and neuroendocrinological studies.
Psychopharmacology 1989;99 Suppl():S13-7.
1989: Herbert Y Meltzer; S Matsubara; J C Lee
The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.
Psychopharmacology bulletin 1989;25(3):390-2.
1989: G A Gudelsky; S A Berry; Herbert Y Meltzer
Actions of typical and atypical antipsychotics on tuberoinfundibular dopamine neurons.
Psychopharmacology bulletin 1989;25(3):377-82.
1989: Herbert Y Meltzer; J Zureick
Negative symptoms in schizophrenia: a target for new drug development.
Psychopharmacology series 1989;7():68-77.
1989: Herbert Y Meltzer; James I Koenig; J F Nash; Gary A Gudelsky
Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs.
Acta psychiatrica Scandinavica. Supplementum 1989;352():24-9.
1989: S Matsubara; Herbert Y Meltzer
Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
Life sciences 1989;45(15):1397-406.
1989: Herbert Y Meltzer; B Bastani; L Ramirez; S Matsubara
Clozapine: new research on efficacy and mechanism of action.
European archives of psychiatry and neurological sciences 1989;238(5-6):332-9.
1988: Herbert Y Meltzer
Race and platelet MAO activity in schizophrenic patients.
Psychiatry research 1988;26(3):337.
1988: M T Lowy; Anthony T Reder; Gleen J Gormley; Herbert Y Meltzer
Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.
Biological psychiatry 1988;24(6):619-30.
1988: John M Kane; G Honigfeld; J Singer; Herbert Y Meltzer
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
Archives of general psychiatry 1988;45(9):789-96.
1988: Herbert Y Meltzer
New insights into schizophrenia through atypical antipsychotic drugs.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1988;1(3):193-6.
1988: J F Nash; Herbert Y Meltzer; Gary A Gudelsky
Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat.
European journal of pharmacology 1988;151(3):463-9.
1988: Herbert Y Meltzer; R C Arora
Genetic control of serotonin uptake in blood platelets: a twin study.
Psychiatry research 1988;24(3):263-9.
1988: Herbert Y Meltzer; M T Lowy; J J Locascio
Platelet MAO activity and the cortisol response to dexamethasone in major depression.
Biological psychiatry 1988;24(2):129-42.
1988: J F Nash; Herbert Y Meltzer; Gary A Gudelsky
Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
The Journal of pharmacology and experimental therapeutics 1988;245(3):873-9.
1988: Marshall L Silverstein; C McDonald; Herbert Y Meltzer
Differential patterns of neuropsychological deficit in psychiatric disorders.
Journal of clinical psychology 1988;44(3):412-5.
1988: J L Zureick; Herbert Y Meltzer
Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis.
Biological psychiatry 1988;24(1):63-78.
1988: M T Lowy; Herbert Y Meltzer
Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist.
Biological psychiatry 1988;23(8):818-28.
1988: James I Koenig; Herbert Y Meltzer; Gary A Gudelsky
5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
Pharmacology, biochemistry, and behavior 1988;29(4):711-5.
1988: J T Metz; Henry H Holcomb; Herbert Y Meltzer
Effect of 5-hydroxytryptophan on H-reflex recovery curves in normal subjects and patients with affective disorders.
Biological psychiatry 1988;23(6):602-11.
1988: J J Locascio; J Lee; Herbert Y Meltzer
Importance of adjusting for correlated concomitant variables in psychiatric research.
Psychiatry research 1988;23(3):311-27.
1988: R C Arora; Herbert Y Meltzer
Effect of desipramine treatment on 3H-imipramine binding in the blood platelets of depressed patients.
Biological psychiatry 1988;23(4):397-404.
1988: R C Arora; Herbert Y Meltzer
Seasonal variation of imipramine binding in the blood platelets of normal controls and depressed patients.
Biological psychiatry 1988;23(3):217-26.
1988: Naomi Breslau; Herbert Y Meltzer
Validity of subtyping psychotic depression: examination of phenomenology and demographic characteristics.
The American journal of psychiatry 1988;145(1):35-40.
1988: John M Kane; G Honigfeld; J Singer; Herbert Y Meltzer
Clozapine in treatment-resistant schizophrenics.
Psychopharmacology bulletin 1988;24(1):62-7.
1988: Gary A Gudelsky; James I Koenig; T Koyama; Herbert Y Meltzer
Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration.
Psychopharmacology 1988;94(1):92-6.
1988: J D Barchas; S W Hadley; T Detre; J Endicott; R Glover; R King; Herbert Y Meltzer; H Sackeim; J S Strauss; P Wahl
A national plan for schizophrenia research: panel recommendations. Research resources.
Schizophrenia bulletin 1988;14(3):439-61.
1987: Herbert Y Meltzer; J L Zureick
Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
Psychiatry research 1987;22(2):99-109.
1987: R L Kettering; Martin Harrow; L Grossman; Herbert Y Meltzer
The prognostic relevance of delusions in depression: a follow-up study.
The American journal of psychiatry 1987;144(9):1154-60.
1987: G A Gudelsky; James I Koenig; Herbert Y Meltzer
Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists.
Neuropharmacology 1987;26(7A):707-12.
1987: James I Koenig; G A Gudelsky; Herbert Y Meltzer
Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.
European journal of pharmacology 1987;137(1):1-8.
1987: R C Arora; R W Kuncl; J Morgan; L Cohen; Herbert Y Meltzer
Serotonin uptake in blood platelets of Duchenne muscular dystrophy patients.
Muscle & nerve 1987;10(4):359-62.
1987: Anthony T Reder; M T Lowy; Herbert Y Meltzer; J P Antel
Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy.
Neurology 1987;37(5):849-53.
1987: M T Lowy; Herbert Y Meltzer
Dexamethasone bioavailability: implications for DST research.
Biological psychiatry 1987;22(3):373-85.
1987: T Koyama; M T Lowy; Herbert Y Meltzer
5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.
The American journal of psychiatry 1987;144(3):334-7.
1987: Herbert Y Meltzer
Biological studies in schizophrenia.
Schizophrenia bulletin 1987;13(1):77-111.
1987: E A Passaro; Herbert Y Meltzer; G A Gudelsky
Effects of acute and chronic dexamethasone treatment on stimulated prolactin secretion in the rat.
Endocrine research 1987;13(2):173-82.
1987: G A Gudelsky; James I Koenig; M Simonovic; T Koyama; T Ohmori; Herbert Y Meltzer
Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat.
Journal of neural transmission 1987;68(3-4):227-40.
1987: Herbert Y Meltzer; M T Lowy; James I Koenig
The hypothalamic-pituitary-adrenal axis in depression.
Advances in biochemical psychopharmacology 1987;43():165-82.
1987: Herbert Y Meltzer
Effect of neuroleptics on the schizophrenic syndrome.
Psychopharmacology series 1987;3():255-65.
1986: R C Arora; Herbert Y Meltzer
Effect of subchronic treatment with imipramine, chlorpromazine and the combination on 3H-imipramine binding in rat blood platelets and frontal cortex.
Life sciences 1986;39(24):2289-96.
1986: G A Gudelsky; James I Koenig; Herbert Y Meltzer
Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.
Neuropharmacology 1986;25(12):1307-13.
1986: Herbert Y Meltzer; A A Sommers; Daniel J Luchins
The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Journal of clinical psychopharmacology 1986;6(6):329-38.
1986: R C Arora; J J Locascio; Herbert Y Meltzer
3H-imipramine binding in blood platelets of schizophrenic patients.
Psychiatry research 1986;19(3):215-24.
1986: Martin Harrow; Linda S Grossman; Marshall L Silverstein; Herbert Y Meltzer; R L Kettering
A longitudinal study of thought disorder in manic patients.
Archives of general psychiatry 1986;43(8):781-5.
1986: Herbert Y Meltzer; B Umberköman-Wiita; A G Robertson; B J Tricou; M Lowy
Correction and amplification: cortisol response to 5-HTP.
Archives of general psychiatry 1986;43(8):815.
1986: James I Koenig; Herbert Y Meltzer; G D Devane; G A Gudelsky
The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
Endocrinology 1986;118(6):2534-9.
1986: R C Arora; Herbert Y Meltzer
Effect of adrenalectomy and corticosterone on [3H]imipramine binding in rat blood platelets and brain.
European journal of pharmacology 1986;123(3):415-9.
1986: J B Cohn; C S Wilcox; Herbert Y Meltzer
Neuroendocrine effects of buspirone in patients with generalized anxiety disorder.
The American journal of medicine 1986;80(3B):36-40.
1986: G A Gudelsky; E Passaro; Herbert Y Meltzer
Delayed activation of tuberoinfundibular dopamine neurons and suppression of prolactin secretion in the rat after morphine administration.
The Journal of pharmacology and experimental therapeutics 1986;236(3):641-5.
1986: Daniel J Luchins; Herbert Y Meltzer
A comparison of CT findings in acute and chronic ward schizophrenics.
Psychiatry research 1986;17(1):7-14.
1986: Herbert Y Meltzer; R C Arora
Platelet markers of suicidality.
Annals of the New York Academy of Sciences 1986;487():271-80.
1986: G A Gudelsky; James I Koenig; H Jackman; Herbert Y Meltzer
Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors.
Psychopharmacology 1986;90(3):403-7.
1986: James I Koenig; Herbert Y Meltzer; G A Gudelsky
Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat.
Neuroendocrinology 1986;43(5):611-7.
1986: Herbert Y Meltzer; J F Nash; James I Koenig; Gary A Gudelsky
Clozapine: neuroendocrine studies of an atypical neuroleptic.
Clinical neuropharmacology 1986;9 Suppl 4():316-8.
1986: T H Andree; M Mikuni; C Y Tong; James I Koenig; Herbert Y Meltzer
Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
Journal of neurochemistry 1986;46(1):191-7.
1985: Gleen J Gormley; M T Lowy; Anthony T Reder; V D Hospelhorn; J P Antel; Herbert Y Meltzer
Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test.
The American journal of psychiatry 1985;142(11):1278-84.
1985: R A Moline; S Singh; A Morris; Herbert Y Meltzer
Family expressed emotion and relapse in schizophrenia in 24 urban American patients.
The American journal of psychiatry 1985;142(9):1078-81.
1985: Daniel J Luchins; R C Arora; Herbert Y Meltzer
Platelet MAO in functional psychoses with evidence of brain atrophy.
The American journal of psychiatry 1985;142(8):996-7.
1985: Herbert Y Meltzer; M Simonovic; G A Gudelsky
Phencyclidine-induced inhibition of rat prolactin secretion: increased portal blood dopamine.
European journal of pharmacology 1985;110(1):143-6.
1985: M T Lowy; A T Reder; Herbert Y Meltzer
Hypercortisolism and depression.
The New England journal of medicine 1985;312(12):791-2.
1985: G A Gudelsky; James I Koenig; Herbert Y Meltzer
Altered responses to serotonergic agents in Fawn-Hooded rats.
Pharmacology, biochemistry, and behavior 1985;22(3):489-92.
1985: R P Roos; Kenneth L Davis; Herbert Y Meltzer
Immunoglobulin studies in patients with psychiatric diseases.
Archives of general psychiatry 1985;42(2):124-8.
1985: R C Arora; V Wunnicke; Herbert Y Meltzer
Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
Biological psychiatry 1985;20(1):116-9.
1985: Herbert Y Meltzer
Long-term effects of neuroleptic drugs on the neuroendocrine system.
Advances in biochemical psychopharmacology 1985;40():59-68.
1984: A K Louie; Herbert Y Meltzer
Lithium potentiation of antidepressant treatment.
Journal of clinical psychopharmacology 1984;4(6):316-21.
1984: R J Moretti; S Z Hassan; L I Goodman; Herbert Y Meltzer
Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality.
Anesthesia and analgesia 1984;63(12):1087-96.
1984: R C Arora; L Kregel; Herbert Y Meltzer
Circadian rhythm of serotonin uptake in the blood platelets of normal controls.
Biological psychiatry 1984;19(11):1579-84.
1984: M T Lowy; Anthony T Reder; J P Antel; Herbert Y Meltzer
Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone.
The American journal of psychiatry 1984;141(11):1365-70.
1984: Herbert Y Meltzer; C Tong; Daniel J Luchins
Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
Biological psychiatry 1984;19(10):1395-402.
1984: Herbert Y Meltzer; Daniel J Luchins
Effect of clozapine in severe tardive dyskinesia: a case report.
Journal of clinical psychopharmacology 1984;4(5):286-7.
1984: D J Burbach; R Lewine; Herbert Y Meltzer
Diagnostic concordance for schizophrenia as a function of sex.
Journal of consulting and clinical psychology 1984;52(3):478-9.
1984: R C Arora; L Kregel; Herbert Y Meltzer
Seasonal variation of serotonin uptake in normal controls and depressed patients.
Biological psychiatry 1984;19(6):795-804.
1984: R J Lewine; Herbert Y Meltzer
Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients.
Psychiatry research 1984;12(2):99-109.
1984: P J Goodnick; R C Arora; H Jackman; Herbert Y Meltzer
Neurochemical changes during discontinuation of lithium prophylaxis. II. Alterations in platelet serotonin function.
Biological psychiatry 1984;19(6):891-8.
1984: P J Goodnick; Herbert Y Meltzer
Neurochemical changes during discontinuation of lithium prophylaxis. I. Increases in clonidine-induced hypotension.
Biological psychiatry 1984;19(6):883-9.
1984: Daniel J Luchins; A G Robertson; Herbert Y Meltzer
Serum prolactin, psychopathology, and ventricular size in chronic schizophrenia.
Psychiatry research 1984;12(2):149-53.
1984: R G Fessler; S N Deyo; Herbert Y Meltzer; R J Miller
Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary.
Brain research 1984;299(2):231-7.
1984: Herbert Y Meltzer; T Kolakowska; V S Fang; Louis Fogg; A Robertson; R Lewine; M Strahilevitz; D Busch
Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
Archives of general psychiatry 1984;41(5):512-9.
1984: Herbert Y Meltzer; R Perline; B J Tricou; M Lowy; A Robertson
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms.
Archives of general psychiatry 1984;41(4):379-87.
1984: Herbert Y Meltzer; B Umberkoman-Wiita; A Robertson; B J Tricou; M Lowy; R Perline
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.
Archives of general psychiatry 1984;41(4):366-74.
1984: Herbert Y Meltzer; M Lowy; A Robertson; P Goodnick; R Perline
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
Archives of general psychiatry 1984;41(4):391-7.
1984: A G Robertson; H Jackman; Herbert Y Meltzer
Prolactin response to morphine in depression.
Psychiatry research 1984;11(4):353-64.
1984: Linda S Grossman; Martin Harrow; J L Fudala; Herbert Y Meltzer
The longitudinal course of schizoaffective disorders. A prospective follow-up study.
The Journal of nervous and mental disease 1984;172(3):140-9.
1984: R C Arora; Herbert Y Meltzer
Imipramine binding in subpopulations of normal human blood platelets.
Biological psychiatry 1984;19(2):257-62.
1984: M Mikuni; G A Gudelsky; M Simonovic; Herbert Y Meltzer
Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.
Life sciences 1984;34(3):239-46.
1984: M Mikuni; Herbert Y Meltzer
Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof.
Life sciences 1984;34(1):87-92.
1984: Herbert Y Meltzer
Schizoaffective disorder: is the news of its nonexistence premature? Editor's introduction.
Schizophrenia bulletin 1984;10(1):11-3.
1984: R Lewine; D Burbach; Herbert Y Meltzer
Effect of diagnostic criteria on the ratio of male to female schizophrenic patients.
The American journal of psychiatry 1984;141(1):84-7.
1984: Herbert Y Meltzer; R C Arora; J Metz
Biological studies of schizoaffective disorders.
Schizophrenia bulletin 1984;10(1):49-70.
1984: G A Gudelsky; Herbert Y Meltzer
Function of tuberoinfundibular dopamine neurons in pargyline- and reserpine-treated rats.
Neuroendocrinology 1984;38(1):51-5.
1984: Herbert Y Meltzer
Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
Annals of the New York Academy of Sciences 1984;430():115-37.
1984: M Simonovic; G A Gudelsky; Herbert Y Meltzer
Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion.
Journal of neural transmission 1984;59(2):143-9.
1984: T H Andree; M Mikuni; Herbert Y Meltzer
Effect of subchronic treatment with neuroleptic, imipramine, and the combination on serotonin receptor binding in rat cerebral cortex.
Psychopharmacology bulletin 1984;20(3):349-53.
1984: Daniel J Luchins; R R Lewine; Herbert Y Meltzer
Lateral ventricular size, psychopathology, and medication response in the psychoses.
Biological psychiatry 1984;19(1):29-44.
1984: P J Goodnick; Herbert Y Meltzer
Treatment of schizoaffective disorders.
Schizophrenia bulletin 1984;10(1):30-48.
1984: G A Gudelsky; M Simonovic; Herbert Y Meltzer
Dopaminergic and serotonergic control of neuroendocrine function.
Monographs in neural sciences 1984;10():85-102.
1983: Herbert Y Meltzer; B Uberkoman-Wiita; A Robertson; B J Tricou; M Lowy
Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania.
Life sciences 1983;33(25):2541-9.
1983: P J Goodnick; C Tong; M B Duncavage; Herbert Y Meltzer
Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Biological psychiatry 1983;18(12):1485-8.
1983: M A Young; R Abrams; M A Taylor; Herbert Y Meltzer
Establishing diagnostic criteria for mania.
The Journal of nervous and mental disease 1983;171(11):676-82.
1983: Daniel J Luchins; Herbert Y Meltzer
Ventricular size and psychosis in affective disorder.
Biological psychiatry 1983;18(10):1197-8.
1983: Herbert Y Meltzer; B J Tricou; A Robertson; M Lowy
Hormone response to 5-HTP.
Psychiatry research 1983;10(2):151-2.
1983: Daniel J Luchins; Herbert Y Meltzer
A blind, controlled study of occipital cerebral asymmetry in schizophrenia.
Psychiatry research 1983;10(2):87-95.
1983: Herbert Y Meltzer; R Flemming; A Robertson
The effect of buspirone on prolactin and growth hormone secretion in man.
Archives of general psychiatry 1983;40(10):1099-102.
1983: Herbert Y Meltzer; M Simonovic; G A Gudelsky
Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
European journal of pharmacology 1983;92(1-2):83-9.
1983: M Simonovic; Herbert Y Meltzer
Biphasic effect of 5-methoxy-N,N-dimethyltryptamine on rat prolactin secretion.
Brain research 1983;272(2):269-75.
1983: R C Arora; C Tong; H L Jackman; D Stoff; Herbert Y Meltzer
Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-hooded and Sprague Dawley rats.
Life sciences 1983;33(5):437-42.
1983: H L Jackman; Herbert Y Meltzer
Kinetic constants of platelet monoamine oxidase in schizophrenia.
The American journal of psychiatry 1983;140(8):1044-7.
1983: H Jackman; Daniel J Luchins; Herbert Y Meltzer
Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.
Biological psychiatry 1983;18(8):887-902.
1983: Herbert Y Meltzer; D Busch
Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
Psychiatry research 1983;9(4):285-99.
1983: Herbert Y Meltzer; D A Busch; V S Fang
Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Psychiatry research 1983;9(4):271-83.
1983: P J Goodnick; Herbert Y Meltzer
Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretion.
Journal of clinical psychopharmacology 1983;3(4):239-43.
1983: Herbert Y Meltzer; R C Arora; P Goodnick
Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders.
Journal of affective disorders 1983;5(3):215-21.
1983: Herbert Y Meltzer; M Simonovic; R So
Effects of a series of substituted benzamides on rat prolactin secretion and 3H-spiperone binding to bovine anterior pituitary membranes.
Life sciences 1983;32(25):2877-86.
1983: G A Gudelsky; E Passaro; Herbert Y Meltzer
Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat.
European journal of pharmacology 1983;90(4):423-5.
1983: M Mikuni; D M Stoff; Herbert Y Meltzer
Effects of combined administration of imipramine and chlorpromazine on beta- and alpha 2-adrenergic receptors in rat cerebral cortex.
European journal of pharmacology 1983;89(3-4):313-6.
1983: Daniel J Luchins; H Jackman; Herbert Y Meltzer
Lateral ventricular size and drug-induced Parkinsonism.
Psychiatry research 1983;9(1):9-16.
1983: R C Arora; Herbert Y Meltzer
Effects of amoxapine on serotonin uptake in human blood platelets of depressed patients and normal controls.
Psychiatry research 1983;9(1):29-36.
1983: R C Arora; Herbert Y Meltzer
Effects of chlorpromazine on serotonin uptake in blood platelets.
Psychiatry research 1983;9(1):23-8.
1983: Herbert Y Meltzer; V S Fang
Cortisol determination and the dexamethasone suppression test. A review.
Archives of general psychiatry 1983;40(5):501-5.
1983: Herbert Y Meltzer; M Mikuni; M Simonovic; G A Gudelsky
Effect of a novel benzamide, YM-09151-2, on rat serum prolactin levels.
Life sciences 1983;32(9):1015-21.
1983: R C Arora; S Sahai; Herbert Y Meltzer
Correlation between MAO activity in blood platelets obtained by single and multiple centrifugations.
Psychiatry research 1983;8(2):147-51.
1983: J Ross-Canada; R A Chizzonite; Herbert Y Meltzer
Retention of sarcoplasmic calcium inhibits development of the phencyclidine-restraint experimental myopathy.
Experimental neurology 1983;79(1):1-10.
1983: Daniel J Luchins; R R Lewine; Herbert Y Meltzer
Lateral ventricular size in the psychoses: relation to psychopathology and therapeutic and adverse response to medications.
Psychopharmacology bulletin 1983;19(3):518-22.
1983: R R Lewine; Louis Fogg; Herbert Y Meltzer
Assessment of negative and positive symptoms in schizophrenia.
Schizophrenia bulletin 1983;9(3):368-76.
1983: Herbert Y Meltzer; Daniel J Luchins
Platelet MAO and family history of schizophrenia: method and madness.
Psychiatry research 1983;8(1):83-5.
1983: Herbert Y Meltzer; R C Arora; B J Tricou; V S Fang
Serotonin uptake in blood platelets and the dexamethasone suppression test in depressed patients.
Psychiatry research 1983;8(1):41-7.
1983: Herbert Y Meltzer; T Kolakowska; A Robertson; B J Tricou
Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor-stimulation strategy.
Psychopharmacology 1983;81(1):37-41.
1983: R C Arora; R G Fessler; Herbert Y Meltzer
Effects of lithium carbonate on serotonin uptake in rat blood platelets.
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(1):39-45.
1983: Herbert Y Meltzer; M Simonovic; G A Gudelsky
Effect of yohimbine on rat prolactin secretion.
The Journal of pharmacology and experimental therapeutics 1983;224(1):21-7.
1983: I F Brockington; Herbert Y Meltzer
The nosology of schizoaffective psychosis.
Psychiatric developments 1983;1(4):317-38.
1982: M Daiguji; Herbert Y Meltzer
Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbens.
European journal of pharmacology 1982;85(3-4):339-42.
1982: I F Brockington; E Altman; V Hillier; Herbert Y Meltzer; S Nand
The clinical picture of bipolar affective disorder in its depressed phase. A report from London and Chicago.
The British journal of psychiatry : the journal of mental science 1982;141():558-62.
1982: W Matuzas; Herbert Y Meltzer; E H Uhlenhuth; R M Glass; C Tong
Plasma dopamine-beta-hydroxylase in depressed patients.
Biological psychiatry 1982;17(12):1415-24.
1982: Herbert Y Meltzer; R Perline; R Lewine
Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine-induced growth hormone response.
The Journal of nervous and mental disease 1982;170(12):758-65.
1982: Herbert Y Meltzer; R Fleming
Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
The Journal of clinical psychiatry 1982;43(12 Pt 2):76-9.
1982: I F Brockington; C Perris; Herbert Y Meltzer
Cycloid psychoses: diagnosis and heuristic value.
The Journal of nervous and mental disease 1982;170(11):651-6.
1982: R C Arora; Herbert Y Meltzer
Serotonin uptake in subpopulations of normal human blood platelets.
Biological psychiatry 1982;17(10):1157-62.
1982: A G Robertson; B J Tricou; V S Fang; Herbert Y Meltzer
Biological markers for depressive illness.
Psychopharmacology bulletin 1982;18(4):120-2.
1982: Herbert Y Meltzer; M B Duncavage; H Jackman; R C Arora; B J Tricou; M Young
Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
The American journal of psychiatry 1982;139(10):1242-8.
1982: S J Nasr; E Altman; G Pscheidt; Herbert Y Meltzer
Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: a preliminary study.
Biological psychiatry 1982;17(8):925-8.
1982: M A Young; Martin A Tanner; Herbert Y Meltzer
Operational definitions of schizophrenia: what do they identify?
The Journal of nervous and mental disease 1982;170(8):443-7.
1982: M Duncavage; Daniel J Luchins; Herbert Y Meltzer
Platelet MAO activity and family history of schizophrenia.
Psychiatry research 1982;7(1):47-51.
1982: M B Bowers; Herbert Y Meltzer; G R Heninger
Correlation of plasma and CSF prolactin with CSF GABA during neuroleptic treatment.
Life sciences 1982;31(1):59-65.
1982: Herbert Y Meltzer; V S Fang; B J Tricou; A Robertson; S K Piyaka
Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
The American journal of psychiatry 1982;139(6):763-8.
1982: R C Arora; Herbert Y Meltzer
Serotonin uptake by blood platelets of schizophrenic patients.
Psychiatry research 1982;6(3):327-33.
1982: Herbert Y Meltzer; D A Busch; B J Tricou; A Robertson
Effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
Psychiatry research 1982;6(3):313-26.
1982: Martin Harrow; Linda S Grossman; Marshall L Silverstein; Herbert Y Meltzer
Thought pathology in manic and schizophrenic patients. Its occurrence at hospital admission and seven weeks later.
Archives of general psychiatry 1982;39(6):665-71.
1982: V S Fang; Herbert Y Meltzer
ACTH levels after the dexamethasone suppression test in depression.
The New England journal of medicine 1982;306(21):1296-7.
1982: Herbert Y Meltzer; Patricia Tueting; H Jackman
The effect of lithium on platelet monoamine oxidase activity in bipolar and schizoaffective disorders.
The British journal of psychiatry : the journal of mental science 1982;140():192-8.
1982: Herbert Y Meltzer; V S Fang; B J Tricou
Dexamethasone and prolactin in depression.
Archives of general psychiatry 1982;39(2):236.
1982: I F Brockington; Herbert Y Meltzer
Documenting an episode of psychiatric illness: need for multiple information sources, multiple raters, and narrative.
Schizophrenia bulletin 1982;8(3):485-92.
1982: Herbert Y Meltzer; R P Liberman
What is schizophrenia?
Schizophrenia bulletin 1982;8(3):433-7.
1982: M Baron; R Perlman; M Levitt; Herbert Y Meltzer; R Gruen; L Asnis
Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
Biological psychiatry 1982;17(1):115-20.
1982: J Metz; D A Busch; Herbert Y Meltzer
Clinical, electrophysiological, and biochemical effects of des-tyrosine-gamma-endorphin in psychiatric patients.
Annals of the New York Academy of Sciences 1982;398():496-508.
1982: R G Fessler; R D Sturgeon; S F London; Herbert Y Meltzer
Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats.
Psychopharmacology 1982;78(4):373-6.
1982: J Metz; Henry H Holcomb; Herbert Y Meltzer
Effect of chlorpromazine on H-reflex recovery curves in normal subjects and schizophrenic patients.
Psychopharmacology 1982;78(4):342-5.
1982: A G Robertson; R Berry; Herbert Y Meltzer
Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients.
Psychopharmacology 1982;78(3):287-92.
1982: R D Sturgeon; R G Fessler; S F London; Herbert Y Meltzer
Behavioral effects of chronic phencyclidine administration in rats.
Psychopharmacology 1982;76(1):52-6.
1982: Herbert Y Meltzer; R So; V S Fang
Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
Advances in biochemical psychopharmacology 1982;35():61-82.
1982: Herbert Y Meltzer; Brinda Wiita; B J Tricou; M Simonovic; V Fang; G Manov
Effect of serotonin precursors and serotonin agonists on plasma hormone levels.
Advances in biochemical psychopharmacology 1982;34():117-39.
1982: Herbert Y Meltzer
Dopamine autoreceptor stimulation: clinical significance.
Pharmacology, biochemistry, and behavior 1982;17 Suppl 1():1-10.
1982: Herbert Y Meltzer; M Simonovic; V S Fang; G A Gudelsky
Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.
Psychopharmacology 1982;78(1):49-53.
1982: Herbert Y Meltzer; V S Fang; B J Tricou; A Robertson
Effect of antidepressants on neuroendocrine axis in humans.
Advances in biochemical psychopharmacology 1982;32():303-16.
1981: Herbert Y Meltzer; R C Arora; R Baber; B J Tricou
Serotonin uptake in blood platelets of psychiatric patients.
Archives of general psychiatry 1981;38(12):1322-6.
1981: R D Sturgeon; R G Fessler; S F London; Herbert Y Meltzer
A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat.
European journal of pharmacology 1981;76(1):37-53.
1981: M Daiguji; Herbert Y Meltzer; C Tong; D C U'Prichard; M Young; H Kravitz
alpha 2-Adrenergic receptors in platelet membranes of depressed patients: no change in number of 3H-yohimbine affinity.
Life sciences 1981;29(20):2059-64.
1981: S Sahai; R C Arora; Herbert Y Meltzer
Platelet monoamine oxidase. I: Effect of temperature, anticoagulant, and centrifugation technique.
Biological psychiatry 1981;16(11):1077-83.
1981: Herbert Y Meltzer; D A Busch; P M Schyve; V S Fang
Effect of (des-Tyr1)-gamma-endorphin on prolactin secretion.
Archives of general psychiatry 1981;38(10):1183.
1981: J Ross-Stanton; Herbert Y Meltzer
Motor neuron branching patterns in psychotic patients.
Archives of general psychiatry 1981;38(10):1097-103.
1981: S Sahai; R C Arora; Herbert Y Meltzer
Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method.
Psychiatry research 1981;5(2):111-4.
1981: S Nasr; E G Altman; Herbert Y Meltzer
Concordance of atopic and affective disorders.
Journal of affective disorders 1981;3(3):291-6.
1981: Herbert Y Meltzer
Prolactin and psychiatry.
The American journal of psychiatry 1981;138(9):1203-6.
1981: V S Fang; B J Tricou; A Robertson; Herbert Y Meltzer
Plasma ACTH and cortisol levels in depressed patients: relation to dexamethasone suppression test.
Life sciences 1981;29(9):931-8.
1981: Herbert Y Meltzer; D A Busch; I R Creese; Solomon H Snyder; V S Fang
Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
Psychiatry research 1981;5(1):95-105.
1981: Herbert Y Meltzer; M Simonovic
Effect of 3-PPP, a putative dopamine autoreceptor agonist, on rat serum prolactin levels.
Life sciences 1981;29(1):99-105.
1981: D J Goode; Herbert Y Meltzer; V S Fang
Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
Biological psychiatry 1981;16(7):653-62.
1981: M Daiguji; Herbert Y Meltzer; D C U'Prichard
Human platelet alpha 2-adrenergic receptors: labeling with 3H-yohimbine, a selective antagonist ligand.
Life sciences 1981;28(24):2705-17.
1981: R C Arora; Herbert Y Meltzer
A modified assay method for determining serotonin uptake in human platelets.
Clinica chimica acta; international journal of clinical chemistry 1981;112(2):225-33.
1981: J Metz; D A Busch; Herbert Y Meltzer
Des-tyrosine-gamma-endorphin: H-reflex response similar to neuroleptics.
Life sciences 1981;28(18):2003-8.
1981: Herbert Y Meltzer; D Busch; V S Fang
Hormones, dopamine receptors and schizophrenia.
Psychoneuroendocrinology 1981;6(1):17-36.
1981: Herbert Y Meltzer; M Simonovic; R D Sturgeon; V S Fang
Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels.
Acta psychiatrica Scandinavica. Supplementum 1981;290():100-21.
1980: R G Fessler; R D Sturgeon; Herbert Y Meltzer
Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
Pharmacology, biochemistry, and behavior 1980;13(6):835-42.
1980: D J Goode; Herbert Y Meltzer; V S Fang
Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women.
Psychoneuroendocrinology 1980;5(4):345-51.
1980: R C Arora; Herbert Y Meltzer
In vitro effect of phencyclidine and other psychomotor stimulants on serotonin uptake in human platelets.
Life sciences 1980;27(17):1607-13.
1980: Herbert Y Meltzer; R D Sturgeon; M Simonovic; R G Fessler
Phencyclidine as an indirect dopamine agonist [proceedings].
Psychopharmacology bulletin 1980;16(4):62-5.
1980: R C Arora; Herbert Y Meltzer
Lithium and serotonin uptake by platelets.
The British journal of psychiatry : the journal of mental science 1980;137():396-7.
1980: Herbert Y Meltzer; S J Nasr; C Tong
Serum dopamine-beta-hydroxylase activity in schizophrenia.
Biological psychiatry 1980;15(5):781-8.
1980: J Ross-Stanton; S Schlessinger; Herbert Y Meltzer
Multiple neuromuscular abnormalities in a paranoid schizophrenic.
Psychiatry research 1980;3(1):53-67.
1980: J Metz; D J Goode; Herbert Y Meltzer
Descriptive studies of H-reflex recovery curves in psychiatric patients.
Psychological medicine 1980;10(3):541-8.
1980: C C Huang; A M Friedman; R So; M Simonovic; Herbert Y Meltzer
Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug.
Journal of pharmaceutical sciences 1980;69(8):984-6.
1980: J D Doherty; M Simonovic; R So; Herbert Y Meltzer
The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum.
European journal of pharmacology 1980;65(2-3):139-49.
1980: G B Kaskey; S Nasr; Herbert Y Meltzer
Drug treatment in delusional depression.
Psychiatry research 1980;2(3):267-77.
1980: Herbert Y Meltzer; V S Fang; M A Young
Clozapine-like drugs.
Psychopharmacology bulletin 1980;16(3):32-5.
1980: Herbert Y Meltzer; J Ross-Stanton; S Schlessinger
Mean serum creatine kinase activity in patients with functional psychoses.
Archives of general psychiatry 1980;37(6):650-5.
1980: Herbert Y Meltzer; R C Arora; R Babar; H Jackman; S Nasr; G Pscheidt; M Smith; M Strahilevitz
Platelet monoamine oxidase activity and schizophrenia.
Archives of general psychiatry 1980;37(3):357.
1980: Herbert Y Meltzer; R C Arora
Skeletal muscle MAO activity in the major psychoses. Relationship with platelet and plasma MAO activities.
Archives of general psychiatry 1980;37(3):333-9.
1980: Herbert Y Meltzer; R C Arora; H Jackman; G Pscheidt; M D Smith
Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
Schizophrenia bulletin 1980;6(2):213-9.
1980: R C Arora; Herbert Y Meltzer
Muscle cholinesterase: effect of phencyclidine and ketamine on rat and human muscle cholinesterase activity.
Experimental neurology 1980;67(1):1-10.
1980: H L Jackman; Herbert Y Meltzer
Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
Communications in psychopharmacology 1980;4(5):335-8.
1980: S Nasr; M Daiguji; C Tong; Herbert Y Meltzer
Comparison of midday serum dopamine-beta-hydroxylase activity in depressed patients and normal controls.
Communications in psychopharmacology 1980;4(4):263-7.
1980: M B Bowers; G R Heninger; D Sternberg; Herbert Y Meltzer
Clinical processes and central dopaminergic activity in psychotic disorders.
Communications in psychopharmacology 1980;4(3):177-83.
1980: Herbert Y Meltzer
Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies.
Schizophrenia bulletin 1980;6(3):456-75.
1980: H L Jackman; Herbert Y Meltzer
Factors affecting determination of platelet monoamine oxidase activity.
Schizophrenia bulletin 1980;6(2):259-66.
1980: Herbert Y Meltzer; H Jackman; R C Arora
Brain and skeletal muscle monoamine oxidase activity in schizophrenia.
Schizophrenia bulletin 1980;6(2):208-12.
1980: M A Young; Herbert Y Meltzer
The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements.
Schizophrenia bulletin 1980;6(1):88-101.
1980: L R Mosher; Herbert Y Meltzer
Drugs and psychosocial treatment: editors' introduction.
Schizophrenia bulletin 1980;6(1):8-9.
1980: M A Young; Herbert Y Meltzer
RMI-81,582, a novel antipsychotic drug.
Psychopharmacology 1980;67(1):101-6.
1979: Herbert Y Meltzer; D J Goode; P M Schyve; M Young; V S Fang
Effect of clozapine on human serum prolactin levels.
The American journal of psychiatry 1979;136(12):1550-5.
1979: R D Sturgeon; R G Fessler; Herbert Y Meltzer
Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats.
European journal of pharmacology 1979;59(3-4):169-79.
1979: Herbert Y Meltzer; R C Arora
Distribution of type A and type B monoamine oxidase activities in rat and chicken skeletal muscle and nerves.
Biochemical pharmacology 1979;28(22):3261-4.
1979: M Simonovic; Herbert Y Meltzer
Repeated administration of 5-methoxy-N,N-dimethyltryptamine to male rats potentiates stimulation of prolactin secretion by serotonin agonists.
European journal of pharmacology 1979;58(4):399-405.
1979: J W Crayton; Herbert Y Meltzer
Degeneration and regeneration of motor neurons in psychotic patients.
Biological psychiatry 1979;14(5):803-19.
1979: D A Busch; V S Fang; Herbert Y Meltzer
Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
Psychiatry research 1979;1(2):153-9.
1979: A J Prange; P T Loosen; I C Wilson; Herbert Y Meltzer; V S Fang
Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin).
Archives of general psychiatry 1979;36(10):1086-93.
1979: H Jackman; R Arora; Herbert Y Meltzer
Comparison of platelet count and platelet protein methods for determination of platelet MAO activity.
Clinica chimica acta; international journal of clinical chemistry 1979;96(1-2):15-23.
1979: Herbert Y Meltzer; R So; R J Miller; V S Fang
Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion.
Life sciences 1979;25(7):573-83.
1979: Herbert Y Meltzer; R So
Effect of morphine, beta-endorphin and leu-enkephalin on 3H-spiroperidol binding to bovine pituitary membranes.
Life sciences 1979;25(6):531-5.
1979: R W Kuncl; Herbert Y Meltzer
Beta adrenergic-mediated myofibrillar disruption and enzyme efflux in an experimental myopathy related to isometric muscle activity.
Experimental and molecular pathology 1979;31(1):113-23.
1979: D J Goode; Herbert Y Meltzer; R Moretti; D J Kupfer; R J McPartland
The relationship between wrist-monitored motor activity and serum CPK activity in psychiatric in-patients.
The British journal of psychiatry : the journal of mental science 1979;135():62-6.
1979: A P West; Herbert Y Meltzer
Paradoxical lithium neurotoxicity: a report of five cases and a hypothesis about risk for neurotoxicity.
The American journal of psychiatry 1979;136(7):963-6.
1979: J Ross-Stanton; Herbert Y Meltzer
Skeletal muscle morphology of depressed patients after medication.
Muscle & nerve 1979;2(3):239-40.
1979: R G Fessler; R D Sturgeon; Herbert Y Meltzer
Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra.
Life sciences 1979;24(14):1281-8.
1979: Herbert Y Meltzer; R G Fessler; M Simonovic; J Doherty; V S Fang
Effect of d- and l-amphetamine on rat plasma prolactin levels.
Psychopharmacology 1979;61(1):63-9.
1979: R W Kuncl; Herbert Y Meltzer
Lesions of the myofibril in myopathic and normal tissue from seven striated muscles. Experimental myopathy of isometric activity produced by phencyclidine and restraint.
Acta neuropathologica 1979;45(2):83-95.
1979: Herbert Y Meltzer; R G Fessler; M Simonovic; D Sturgeon
PCP: neurochemistry, treatment, and more.
The American journal of psychiatry 1979;136(2):235-7.
1979: D J Goode; Herbert Y Meltzer; T A Mazura
Hoffmann reflex abnormalities in psychotic patients.
Biological psychiatry 1979;14(1):95-110.
1979: P S Holzman; Herbert Y Meltzer; E Kringlen; Deborah Levy; S J Haberman; John M Davis
Plasma CPK levels in monozygotic and dizygotic twins discordant for schizophrenia.
Journal of psychiatric research 1979;15(2):127-31.
1979: H W Cho; Herbert Y Meltzer
Factors affecting stability of isozymes of creatine phosphokinase.
American journal of clinical pathology 1979;71(1):75-82.
1979: Herbert Y Meltzer; D J Goode; R C Arora
Neuromuscular dysfunction and vulnerability to psychosis.
Psychopharmacology bulletin 1979;15(1):43-4.
1979: Herbert Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.
Journal of neural transmission 1979;45(2):165-75.
1979: Herbert Y Meltzer
Clinical evidence for multiple dopamine receptors in man.
Communications in psychopharmacology 1979;3(6):457-70.
1979: Herbert Y Meltzer
Biology of schizophrenia subtypes: a review and proposal for method of study.
Schizophrenia bulletin 1979;5(3):460-79.
1978: Herbert Y Meltzer
Creatine phosphokinase activity in blacks vs whites.
Archives of internal medicine 1978;138(11):1750.
1978: P M Schyve; F Smithline; Herbert Y Meltzer
Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
Archives of general psychiatry 1978;35(11):1291-1301.
1978: Herbert Y Meltzer; M Simonovic; R G Fessler
Neuropharmacological studies of prolactin secretion.
Psychopharmacology bulletin 1978;14(4):26-9.
1978: Herbert Y Meltzer; D Stanisic; M Simonovic; V S Fang
Ketamine as an anesthetic for obtaining plasma for rat prolactin assays.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1978;159(1):12-5.
1978: Herbert Y Meltzer; R G Fessler; M Simonovic; V S Fang
The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
Life sciences 1978;23(11):1185-92.
1978: Herbert Y Meltzer; M Simonovic; V Fang; S Piyakalamala; M Young
A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
Life sciences 1978;23(6):605-9.
1978: Herbert Y Meltzer; R J Miller; R G Fessler; M Simonovic; V S Fang
Effects of enkephalin in analogues on prolactin release in the rat.
Life sciences 1978;22(21):1931-7.
1978: Herbert Y Meltzer
Mechanisms of antipsychotic effect in treatment of acute schizophrenia.
Lancet 1978;1(8074):1151-2.
1978: Herbert Y Meltzer; R G Fessler; M Simonovic; V S Fang
Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.
Psychopharmacology 1978;56(3):255-9.
1978: S M Stahl; Herbert Y Meltzer
A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human platelets and platelet storage granules: comparison with central serotonergic neurons.
The Journal of pharmacology and experimental therapeutics 1978;205(1):118-32.
1978: Herbert Y Meltzer; E Dorus; L Grunhaus; John M Davis; R Belmaker
Genetic control of human plasma creatine phosphokinase activity.
Clinical genetics 1978;13(4):321-6.
1978: S M Stahl; Herbert Y Meltzer
The human platelet as a model for the dopaminergic neuron: kinetic and pharmacologic properties and the role of amine storage granules.
Experimental neurology 1978;59(1):1-15.
1978: V S Fang; H W Cho; Herbert Y Meltzer
Enzymic, electrophoretic and immunoreactive properties of labeled MM and BB isoenzymes of human creatine kinase.
Enzyme 1978;23(3):210-4.
1978: Herbert Y Meltzer; V S Fang; D J Goode
Prolactin and neuroleptics: clinical implications for efficacy and toxicity. The effect of neuroleptics and alpha-methyl-para-tyrosine on serum prolactin levels in laboratory animals and man.
Psychopharmacology bulletin 1978;14(1):5-7.
1978: P M Schyve; F Smithline; Herbert Y Meltzer
Prolactin and breast cancer.
Psychopharmacology bulletin 1978;14(1):17-9.
1978: Herbert Y Meltzer; R G Fessler; V S Fang
Effect of piperoxane on rat plasma prolactin.
Communications in psychopharmacology 1978;2(3):237-42.
1978: Herbert Y Meltzer; M Simonovic; V S Fang
The effect of muscimol on prolactin secretion in male rats.
Communications in psychopharmacology 1978;2(3):231-6.
1978: V S Fang; B T Ho; Herbert Y Meltzer
Effect of 6-methoxy-tetrahydro-beta-carboline on serum prolactin levels of male rats.
Communications in psychopharmacology 1978;2(1):59-63.
1978: T Ziemba; Herbert Y Meltzer; John M Davis
Do anticholinergic antagonize antipsychotic drug action?
Schizophrenia bulletin 1978;4(1):7-12.
1977: D J Goode; D H Weinberg; T A Mazura; G Curtiss; R J Moretti; Herbert Y Meltzer
Effect of limb restraints on serum creatine phosphokinase activity in normal volunteers.
Biological psychiatry 1977;12(6):743-55.
1977: R W Kuncl; Herbert Y Meltzer
Role of the adrenal in an experimental myopathy.
Experimental neurology 1977;57(2):322-30.
1977: Herbert Y Meltzer; R G Fessler; V S Fang
Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
Psychopharmacology 1977;54(2):183-6.
1977: V S Fang; H W Cho; Herbert Y Meltzer
Radioimmunoassay for MM and BB isoenzymes of creatine kinase substantiated by clinical application.
Clinical chemistry 1977;23(10):1898-902.
1977: Herbert Y Meltzer; R G Fessler; M Simonovic; J Doherty; V S Fang
Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.
Psychopharmacology 1977;54(1):39-44.
1977: R C Smith; Herbert Y Meltzer; R C Arora; John M Davis
Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain.
Biochemical pharmacology 1977;26(15):1435-9.
1977: J W Crayton; Herbert Y Meltzer; D J Goode
Motoneuron excitability in psychiatric patients.
Biological psychiatry 1977;12(4):545-61.
1977: R C Arora; Herbert Y Meltzer
Isoenzymes of manoamine oxidase in human skeletal muscle.
Experimental neurology 1977;55(2):318-26.
1977: Herbert Y Meltzer; V S Fang
Effect of gamma-butyrolactone and baclofen on plasma prolactin in male rats.
Biochemical pharmacology 1977;26(7):645-6.
1977: Herbert Y Meltzer; V S Fang; M Simonovich; S M Paul
Effect of metabolites of chlorpromazine on plasma prolactin levels in male rats.
European journal of pharmacology 1977;41(4):431-6.
1977: H W Cho; L Prilipko; Herbert Y Meltzer; C Keller
Isoenzymes of creatine phosphokinase in white blood cells.
Experientia 1977;33(2):166-7.
1977: Herbert Y Meltzer; S Piyakalmala; P Schyve; V S Fang
Lack of effect of tricyclic antidepressants on serum prolactin levels.
Psychopharmacology 1977;51(2):185-7.
1977: Herbert Y Meltzer; S M Paul; V S Fang
Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
Psychopharmacology 1977;51(2):181-3.
1977: D J Goode; Herbert Y Meltzer; J W Crayton; T A Mazura
Physiologic abnormalities of the neuromuscular system in schizophrenia.
Schizophrenia bulletin 1977;3(1):121-38.
1977: Herbert Y Meltzer; D J Goode; V S Fang
Effects of chlorpromazine on plasma prolactin and chlorpromazine levels [proceedings].
Psychopharmacology bulletin 1977;13(1):59-60.
1977: S M Stahl; Herbert Y Meltzer
Serotonin accumulation by skeletal muscle.
Experimental neurology 1977;54(1):42-53.
1977: R C Arora; Herbert Y Meltzer
Characterization of rat skeletal muscle monoamine oxidase.
Biochemical pharmacology 1977;26(1):45-9.
1976: J W Crayton; Herbert Y Meltzer
Motor endplate alterations in schizophrenic patients.
Nature 1976;264(5587):658-9.
1976: H W Cho; Herbert Y Meltzer; J I Joung; D Goode
Effect of incubation in human plasma on electrophoretic mobility of brain-type creatine phosphokinase.
Clinica chimica acta; international journal of clinical chemistry 1976;73(2):257-65.
1976: K T Finnegan; M I Kanner; Herbert Y Meltzer
Phencyclidine-induced rotational behavior in rats with nigrostriatal lesions and its modulation by dopaminergic and cholinergic agents.
Pharmacology, biochemistry, and behavior 1976;5(6):651-60.
1976: Herbert Y Meltzer; D J Goode; V S Fang; P Schyve; M Young
Dopamine and schizophrenia.
Lancet 1976;2(7995):1142.
1976: Herbert Y Meltzer; S Z Hassan; P Russo; H W Cho
Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.
Anesthesia and analgesia 1976;55(6):797-9.
1976: Herbert Y Meltzer
Creatine phosphokinase activity in blacks.
Archives of internal medicine 1976;136(11):1336.
1976: Herbert Y Meltzer
Dopamine receptors and average clinical doses.
Science (New York, N.Y.) 1976;194(4264):545-6.
1976: Herbert Y Meltzer; V S Fang; S M Paul; R Kaluskar
Effect of quipazine on rat plasma prolactin levels.
Life sciences 1976;19(7):1073-8.
1976: D J Goode; Herbert Y Meltzer
Effects of isometric exercise on serum creatine phosphokinase activity.
Archives of general psychiatry 1976;33(10):1207-11.
1976: Herbert Y Meltzer; R W Kuncl; V Yang
Incidence of Z band streaming and myofibrillar disruptions in skeletal muscle from healthy young people.
Neurology 1976;26(9):853-7.
1976: Herbert Y Meltzer; S Rastogi; J Ellison
Quantitative histochemical evaluation of normal human skeletal muscle.
Neurology 1976;26(9):849-52.
1976: G R Pscheidt; Herbert Y Meltzer
Siliconising agent inhibits platelet M.A.O.
Lancet 1976;2(7983):474.
1976: R C Arora; Herbert Y Meltzer
In vitro and in vivo inhibition of rat liver, brain and muscle monoamine oxidase by chlorpromazine and imipramine.
Research communications in chemical pathology and pharmacology 1976;14(4):755-8.
1976: J W Crayton; Herbert Y Meltzer
Serum creatine phosphokinase activity in psychiatrically hospitalized children.
Archives of general psychiatry 1976;33(6):679-81.
1976: Herbert Y Meltzer; H W Cho; B J Carroll; P Russo
Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients.
Archives of general psychiatry 1976;33(5):585-91.
1976: Herbert Y Meltzer
Skeletal muscle necrosis following membrane-active drugs plus serotonin.
Journal of the neurological sciences 1976;28(1):41-56.
1976: Herbert Y Meltzer; R Belmaker; R J Wyatt; W Pollin; S Cohen
Serum creatine phosphokinase (CPK) activity in monozygotic twins discordant for schizophrenia: heritability of serum CPK activity.
Comprehensive psychiatry 1976;17(3):469-75.
1976: Herbert Y Meltzer; V S Fang
The effect of neuroleptics on serum prolactin in schizophrenic patients.
Archives of general psychiatry 1976;33(3):279-86.
1976: Herbert Y Meltzer
Serum creatine phosphokinase in schizophrenia.
The American journal of psychiatry 1976;133(2):192-7.
1976: Herbert Y Meltzer; V S Fang
Effect of apomorphine plus 5-hydroxytryptophan on plasma prolactin levels in male rats.
Psychopharmacology communications 1976;2(3):189-98.
1976: Herbert Y Meltzer; S M Stahl
The dopamine hypothesis of schizophrenia: a review.
Schizophrenia bulletin 1976;2(1):19-76.
1976: Herbert Y Meltzer
Neuromuscular dysfunction in schizophrenia.
Schizophrenia bulletin 1976;2(1):106-35.
1976: Herbert Y Meltzer
Biochemical studies in schizophrenia.
Schizophrenia bulletin 1976;2(1):10-8.
1975: Herbert Y Meltzer
Plasma creatine phosphokinase levels in rats following lysergic acid diethylamide.
Psychopharmacologia 1975;44(1):91-3.
1975: Herbert Y Meltzer; S Daniels; V S Fang
Clozapine increases rat serum prolactin levels.
Life sciences 1975;17(3):339-42.
1975: V S Fang; H W Cho; Herbert Y Meltzer
Labeling of creatine phosphokinase without loss of enzyme activity.
Biochemical and biophysical research communications 1975;65(1):413-9.
1975: M Strahilevitz; N Narasimhachari; G W Fischer; Herbert Y Meltzer; H E Himwich
Indolethylamine-N-methyltransferase activity in psychiatric patients and controls.
Biological psychiatry 1975;10(3):287-302.
1975: Herbert Y Meltzer; S Z Hassan; R Moretti; C Hengeveld; D Bruckner
Letter: Effect of ketamine on creatine phosphokinase levels.
Lancet 1975;1(7917):1195-6.
1975: Herbert Y Meltzer
Letter: serum creatine kinase in acute psychosis.
The British journal of psychiatry : the journal of mental science 1975;126():489-90.
1975: D J Goode; Herbert Y Meltzer
The role of isometric muscle tension in the production of muscle toxicity by phencyclidine and restraint stress.
Psychopharmacologia 1975;42(1):105-8.
1975: G R Pscheidt; Herbert Y Meltzer
Letter: Lithium and pyruvate kinase.
Lancet 1975;1(7912):932.
1975: Herbert Y Meltzer
Lack of effect of ouabain on creatine phosphokinase efflux from skeletal muscle.
Biochemical pharmacology 1975;24(3):419-21.
1975: Herbert Y Meltzer; E J Sachar; A G Frantz
Dopamine antagonism by thioridazine in schizophrenia.
Biological psychiatry 1975;10(1):53-7.
1975: M Kanner; K Finnegan; Herbert Y Meltzer
Dopaminergic effects of phencyclidine in rats with nigrostriatal lesions.
Psychopharmacology communications 1975;1(4):393-401.
1975: Herbert Y Meltzer; J W Crayton
Neuromuscular abnormalities in the major mental illnesses. II. Muscle fiber and subterminal motor nerve abnormalities.
Research publications - Association for Research in Nervous and Mental Disease 1975;54():189-207.
1975: Herbert Y Meltzer
Neuromuscular abnormalities in the major mental illnesses. I. Serum enzyme studies.
Research publications - Association for Research in Nervous and Mental Disease 1975;54():165-88.
1974: R W Kuncl; Herbert Y Meltzer
Pathologic effect of phencyclidine and restraint on rat skeletal muscle structure: prevention by prior denervation.
Experimental neurology 1974;45(2):387-402.
1974: Herbert Y Meltzer; E J Sachar; A G Frantz
Serum prolactin levels in unmedicated schizophrenic patients.
Archives of general psychiatry 1974;31(4):564-9.
1974: H W Cho; Herbert Y Meltzer
Mg++-dependent adenosine triphosphatase activity in erythrocyte ghosts of schizophrenic patients.
Biological psychiatry 1974;9(2):109-16.
1974: D J Goode; Herbert Y Meltzer
Cytotoxic effects of imipramine on platelets.
Biochemical pharmacology 1974;23(18):2629-35.
1974: Herbert Y Meltzer
Letter: Interpretation of CPK activity.
JAMA : the journal of the American Medical Association 1974;229(9):1169.
1974: P S Holzman; L R Proctor; Deborah Levy; N J Yasillo; Herbert Y Meltzer; S W Hurt
Eye-tracking dysfunctions in schizophrenic patients and their relatives.
Archives of general psychiatry 1974;31(2):143-51.
1974: Herbert Y Meltzer
Letter: Creatine phosphokinase and psychiatric illness.
The British journal of psychiatry : the journal of mental science 1974;125(0):219-20.
1974: Herbert Y Meltzer; P A Holy
Black-white differences in serum creatine phosphokinase (CPK) activity.
Clinica chimica acta; international journal of clinical chemistry 1974;54(2):215-24.
1974: Herbert Y Meltzer; E J Sachar; A G Frantz
Proceedings: Serum prolactin levels in newly admitted psychiatric patients.
Psychopharmacology bulletin 1974;10(3):14-5.
1974: Herbert Y Meltzer; J W Crayton
Subterminal motor nerve abnormalities in psychotic patients.
Nature 1974;249(455):373-5.
1974: Herbert Y Meltzer; J W Crayton
Muscle abnormalities in psychotic patients. II. Serum CPK activity, fiber abnormalities, and branching and sprouting of subterminal nerves.
Biological psychiatry 1974;8(2):191-208.
1974: Herbert Y Meltzer; S M Stahl
Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
Research communications in chemical pathology and pharmacology 1974;7(2):419-31.
1974: Herbert Y Meltzer; E J Sachar; A G Frantz
Serum prolactin levels in newly admitted psychiatric patients.
Advances in biochemical psychopharmacology 1974;12(0):299-315.
1973: Herbert Y Meltzer
Creatine phosphokinase activity and clinical symptomatology. A study in acute schizophrenic patients.
Archives of general psychiatry 1973;29(5):589-93.
1973: D J Goode; H Dekirmenjian; Herbert Y Meltzer; J W Maas
Relation of exercise to MHPG excretion in normal subjects.
Archives of general psychiatry 1973;29(3):391-6.
1973: Herbert Y Meltzer
Plasma creatine phosphokinase activity in the rat after tenotomy or denervation.
Experimental neurology 1973;40(2):547-51.
1973: Herbert Y Meltzer
Morphological effects of Compound 48-80, polymyxin B sulfate, and dextran on rat skeletal muscle.
Archives of pathology 1973;96(2):118-23.
1973: Herbert Y Meltzer; E McBride; R W Poppei
Rod (nemaline) bodies in the skeletal muscle of an acute schizophrenic patient.
Neurology 1973;23(7):769-80.
1973: Herbert Y Meltzer
Skeletal muscle abnormalities in patients with affective disorders.
Journal of psychiatric research 1973;10(1):43-57.
1973: Herbert Y Meltzer; P Margulies; H W Cho
Release of creatine phosphokinase from muscle. II. Effect of multiple doses of polymyxin B or compound 48-80 on increases in plasma enzyme levels.
Biochemical pharmacology 1973;22(7):857-63.
1973: Herbert Y Meltzer
Serum creatine phosphokinase activity in acute psychosis.
The British journal of psychiatry : the journal of mental science 1973;122(568):369.
1973: Herbert Y Meltzer
Effect of theophylline on alkaline phosphatase activity of denervated skeletal muscle fibers.
Research communications in chemical pathology and pharmacology 1973;5(2):539-42.
1973: Herbert Y Meltzer
Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
Psychopharmacologia 1973;29(4):337-46.
1973: Herbert Y Meltzer
Effects of phencyclidine and restraint at 2 degrees C on rat plasma creatine phosphokinase activity.
Research communications in chemical pathology and pharmacology 1973;5(1):117-27.
1972: Herbert Y Meltzer
Central core fibers in an acutely psychotic patient. Evidence for a neurogenic basis for the muscle abnormalities in the acute psychoses.
Archives of general psychiatry 1972;27(1):125-32.
1972: Herbert Y Meltzer
Muscle toxicity produced by phencyclidine and restraint stress.
Research communications in chemical pathology and pharmacology 1972;3(2):369-82.
1972: Herbert Y Meltzer; P S Holzman; S Z Hassan; A Guschwan
Effects of phencyclidine and stress on plasma creatine phosphokinase (CPK) and aldolase activities in man.
Psychopharmacologia 1972;26(1):44-53.
1971: Herbert Y Meltzer; P Margulies
Release of creatine phosphokinase from muscle. I. Effect of polymyxin B, compound 48-80, and serotonin.
Biochemical pharmacology 1971;20(12):3501-8.
1971: Herbert Y Meltzer
Plasma creatine phosphokinase activity, hypothermia, and stress.
The American journal of physiology 1971;221(3):896-901.
1971: Herbert Y Meltzer; R Nankin; J Raftery
Serum creatine phosphokinase activity in newly admitted psychiatric patients. II.
Archives of general psychiatry 1971;24(6):568-72.
1971: Herbert Y Meltzer
Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity and age.
Clinica chimica acta; international journal of clinical chemistry 1971;33(1):165-72.
1971: N Narasimhachari; B Heller; J Spaide; L Haskovec; Herbert Y Meltzer; M Strahilevitz; H E Himwich
N,N-dimethylated indoleamines in blood.
Biological psychiatry 1971;3(1):21-3.
1970: Herbert Y Meltzer; R Moline
Muscle abnormalities in acute psychoses.
Archives of general psychiatry 1970;23(6):481-91.
1970: Herbert Y Meltzer; W King Engel
Histochemical abnormalities of skeletal muscle in acutely psychotic patients. II.
Archives of general psychiatry 1970;23(6):492-502.
1970: D A Fischman; Herbert Y Meltzer; R W Poppei
Disruption of myofibrils in the skeletal muscle of psychotic patients.
Archives of general psychiatry 1970;23(6):503-15.
1970: D J Kupfer; Herbert Y Meltzer; R J Wyatt; F Snyder
Serum enzyme changes during sleep deprivation.
Nature 1970;228(5273):768-70.
1970: Herbert Y Meltzer; L Grinspoon; R I Shader
Serum creatine phosphokinase and aldolase activity in acute schizophrenic patients and their relatives.
Comprehensive psychiatry 1970;11(6):552-8.
1970: Herbert Y Meltzer
Increased activity of creatine phosphokinase and aldolase activity in the acute psychoses: case reports.
Journal of psychiatric research 1970;7(4):249-62.
1970: Herbert Y Meltzer; R Moline
Plasma enzymatic activity after exercise. Study of psychiatric patients and their relatives.
Archives of general psychiatry 1970;22(5):390-7.
1970: Herbert Y Meltzer; D J Kupfer; R Wyatt; F Snyder
Sleep disturbance and serum CPK activity in acute psychosis.
Archives of general psychiatry 1970;22(5):398-405.
1970: W King Engel; Herbert Y Meltzer
Histochemical abnormalities of skeletal muscle in patients with acute psychoses.
Science (New York, N.Y.) 1970;168(3928):273-6.
1970: Herbert Y Meltzer; S Mrozak; M Boyer
Effect of intramuscular injections on serum creatine phosphokinase activity.
The American journal of the medical sciences 1970;259(1):42-8.
1969: Herbert Y Meltzer; M Boyer
Effect of blood serum or plasma from schizophrenic patients and others on an action of 3,4-dimethoxyphenylethylamine: a failure to replicate.
Archives internationales de pharmacodynamie et de thérapie 1969;182(2):481-8.
1969: Herbert Y Meltzer
Muscle enzyme release in the acute psychoses.
Archives of general psychiatry 1969;21(1):102-12.
1969: Herbert Y Meltzer
Intramuscular chlorpromazine and creatine kinase: acute psychoses or local muscle trauma?
Science (New York, N.Y.) 1969;164(3880):726-7.
1969: Herbert Y Meltzer; R Shader; L Grinspoon
The behavioral effects of nicotinamide adenine dinucleotide in chronic schizophrenia.
Psychopharmacologia 1969;15(2):144-52.
1968: Herbert Y Meltzer
Creatine kinase and aldolase in serum: abnormality common to acute psychoses.
Science (New York, N.Y.) 1968;159(3821):1368-70.
1962: Herbert Y Meltzer
The effect of pyridine aldoxime dodecyliodide on monamine oxidase and bound amines.
Biochemical pharmacology 1962;11():617-25.
1961: Herbert Y Meltzer
The effect of thiamine on monoamine oxidase.
Biochemical pharmacology 1961;7():277-8.